NMR studies of the conformation of a triazine dendrimer and the synthesis of a platinated triazine dendrimer by Moreno, Karlos Xavier
  
 
 
 
NMR STUDIES OF THE CONFORMATION OF A TRIAZINE DENDRIMER 
AND THE SYNTHESIS OF A PLATINATED TRIAZINE DENDRIMER 
 
 
A Dissertation 
by 
KARLOS XAVIER MORENO  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
December 2007 
 
 
Major Subject: Chemistry 
  
 
 
 
NMR STUDIES OF THE CONFORMATION OF A TRIAZINE DENDRIMER 
AND THE SYNTHESIS OF A PLATINATED TRIAZINE DENDRIMER 
 
A Dissertation 
by 
KARLOS XAVIER MORENO  
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
Approved by: 
Chair of Committee,  Eric E. Simanek 
Committee Members, David E. Bergbreiter 
 François P. Gabbaї 
 Andy C. LiWang 
Head of Department, David H. Russell 
 
December 2007 
 
Major Subject: Chemistry 
 iii
ABSTRACT 
 
NMR Studies of the Conformation of a Triazine Dendrimer and the Synthesis of a 
Platinated Triazine Dendrimer. (December 2007) 
Karlos Xavier Moreno, B.S., The University of Texas at San Antonio 
Chair of Advisory Committee: Dr. Eric E. Simanek 
 
A general picture of dendrimer conformation has appeared through studies of various 
dendrimer systems.  Though the studies define some conformational abilities of a 
dendrimer, the studies are only able to examine one portion of the general picture.  NMR 
studies of a generation three melamine dendrimer with unique NMR signatures from 
core to periphery describes most, if not all, of the general concepts of dendrimers in one 
system. 
A generation three melamine dendrimer was synthesized by a convergent route using 
diamines identified from competition reactions towards a monochlorotriazine.  The 
cyclic monoamines surveyed displayed a relative reactivity range of 40x, expanding the 
previously identified series to a range of 320x.  Azetidine is 40x more reactive than the 
cyclic, nine-membered ring (C8H17N), and 320x more reactive than benzyl amine.  
Sterics and pKa values explain the differences in reactivity of the cyclic monoamines.  
Differences in the nucleophilicity of the amine groups consisting of 2-aminoazetidine, 2-
aminopyrrolidine, and 4-aminopiperidine are 180x, 70x and 20x, respectively. 
 iv
One-dimensional NMR spectra of the exchangeable NH region show that the 
dendrimer supports a rich rotamer population.  Observations of the data show that the 
rotamer populations change from a preferred extended conformation to a more closed 
conformation, indicative of sterics being a driving force of conformational architecture.  
Variable temperature NOESY studies show that the peripheral groups backfold into the 
interior of the dendrimer in DMSO- d6.  The backfolding can be removed by changing 
the solvent to either CDCl3 or CD3OD.  Variable temperature (VT) coefficients 
measured for the exchangeable NH protons implies that solvent may be excluded from 
the interior of the dendrimer.  Proton relaxation studies provide evidence that the 
dendrimer tumbles slowly in solution, and the periphery moves more freely than the 
interior. 
Synthesis towards the attachment of carboplatin-like peripheral groups on a 
generation three dendrimer was unsuccessful.  A diethyl malonate unit was attached to 
the periphery of the dendrimer followed by capping with 4-aminomethylpiperidine.  
Hydrolysis of the esters and treatment with activated platinum led to a black precipitate 
product.  Two alternate routes of achieving the desired platinated dendrimer are 
described. 
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CHAPTER I 
INTRODUCTION:  CONFORMATIONAL ANALYSIS OF NON-TRIAZINE 
DENDRIMERS 
 
Introduction 
Ideally, dendrimers are perfect monodisperse macromolecules with a regular and 
highly branched three-dimensional architecture.1  Synthesis of dendrimers proceeds 
through an iterative process, in which each additional iteration leads to a higher 
generation material.  The first reported iterative synthesis was by Vögtle, who named 
this procedure a ‘cascade synthesis’.2  Some of the most frequently studied dendrimers 
are Tomalia’s poly(amidoamine) (PAMAM) dendrimers,3 Fréchet’s poly(aryl ether) 
dendrimers4 and Meijer’s poly(propylene imine) (PPI) dendrimers5 (Figure 1.1). 
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Figure 1.1.  Examples of a PAMAM, a Poly(Aryl Ether) and a PPI dendrimer. 
 
 
 
______________ 
This dissertation follows the style of The Journal of the American Chemical Society.   
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Dendrimers may be synthesized in two ways:  divergently3 or convergently4 (Figure 
1.2).  Each synthetic route has advantages and disadvantages.  In the divergent synthesis, 
the dendrimer is grown stepwise from the core.  The number of reactions required to 
complete in each step increases exponentially.  As the dendrimer grows, completion of 
each step becomes more difficult leaving incomplete reactions.  Achieving large 
quantities quickly and high generation dendrimers is possible through the divergent 
method.  In the convergent synthesis, the dendrimer is grown from the periphery towards 
the core.  The number of reactions required to complete each step is kept low and 
constant providing higher purity material.  Sterics prohibits high generation dendrimer 
synthesis. 
 
 
Divergent Convergent
 
Figure 1.2.  Illustration of divergent and convergent pathways of dendrimer synthesis. 
 
 
 
 3
One of the fundamental questions to ask about macromolecules is, “What 
conformation does the molecule adopt in solution?” or “How does it interact with its 
local environment?”  Since the first reported synthesis of dendrimers,1-3 there have been 
many efforts to determine the conformation of the macromolecules in solution using 
both experiment and theory.6-41
Computational Studies 
Using a self consistent-field model, de Gennes and Hervet proposed that the 
dendrimer extends outwardly from the core having all of the end groups on or near the 
periphery of the molecule (i.e., dense shell).6  Starburst growth was determined to exist 
within only a finite number of generations.  Their concluding thoughts were that the 
molecule is very flexible for small generations but very rigid in higher generations.  
Naylor et al. used computer–assisted molecular modeling to conclude that generations 1-
3 are highly asymmetric and generations 5-7 are nearly symmetrical.7  Generation 4 was 
believed to be the transition between the asymmetric and symmetrical forms.  The 
average structures for the early generations were very open, domed shapes, while the 
latter generations were more dense and spheroid-like.  
In contrast, Lescanec and Muthukumar’s simplified kinetic model using a computer 
simulation of dendritic growth found that the chain ends may reside within the molecule 
for a given generation.8  A maximum density between the core and the periphery derives 
from a backfolding of the chain ends.  A more recent self consistent-field model by 
Boris and Rubinstein supports the dense core model: density decreased monotonically 
from the center of the molecule.9  Monte Carlo calculations performed by Mansfield and 
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Klushin found the chain ends to be distributed throughout the structure.10  The 
calculations revealed some hollowness may be present through a range of dendrimer 
generations.  This occurs with the core maximally extended, creating cavities within the 
architecture and the end groups backfold inadequately filling these voids.  Also using 
Monte Carlo calculations, Welch and Muthukumar observed that under low electrostatic 
conditions, the end groups are located near the surface of the molecule.11  By increasing 
the salt concentration, the molecule rearranges to a more dense core architecture. 
Molecular dynamics (MD) simulations of dendrimers that incorporate solvent effects 
have been performed.12-14  Murat and Grest provided a model which predicted 
backfolding of the chain ends for various solvent qualities.12  Their conditions provided 
a high density core and an increase in dendrimer density with a decrease in solvent 
quality.  More recently, MD simulations performed in explicit solvent have suggested 
that dendrimers can backfold in solution.13,14  Karatasos et al. found that as the 
generation of the dendrimer increases the extent of backfolding also increases.13  
‘Dynamic layering’ was observed in the simulation.  The authors find that the internal 
layer of the dendrimer has slow dynamics, while the peripheral layer has fast dynamics:  
‘slow layer’ and ‘fast layer’, respectively.  Suek and Lamm studied both solvophobic 
and solvophilic dendrimers and found that in solvophobic dendrimers the maximum 
density is located near the core.14  The density decreased as the dendrimer exterior is 
approached.  In solvophilic dendrimers of less than generation six, the peripheral groups 
were found to be extended away from the core.  For G6 or greater, the peripheral groups 
were found throughout the molecule possibly forced back due to steric crowding.  In 
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summary, most of the theoretical studies suggest that backfolding is a common process 
of dendrimers. 
Poly(amidoamine) (PAMAM) Dendrimers 
Using hydrodynamic radius values, Tomalia et al observed a change in conformation 
as the generation of poly(amidoamine) PAMAM dendrimers increased (Figure 1.3).15  
Plotting the hydrodynamic radii values vs generation number gave a linear relationship 
fro generations 1.0-3.5.  However, the authors noticed a slight deviation for higher 
generations towards values displayed by extended CPK values.  The deviation was 
thought to be the dendrimer being engorged (extended) solvent or a sterically induced 
hollowness (extension) was observed.  Meltzer et al. demonstrated that the chain 
dynamics did not change dramatically up to the tenth generation using NMR 
spectroscopy.16,17  The relaxation of the interior carbons was faster than the exterior 
carbons.  Relaxation of the terminal carbons decreased as the molecular weight of the 
dendrimer increased.  They conclude that the branches backfold to some extent to relieve 
steric crowding based on 2H NMR.  Small-angle X-ray scattering (SAXS) measurements 
showed that the density of the dendrimer with a molecular weight greater than 50 kDa 
appears to be independent of the generation.18  The terminal groups were able to reside 
on the surface of the molecule but backfolded arrangements were possible. 
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Figure 1.3.  G1 examples of PAMAM dendrimers studied by Tomalia15 and Meltzer.16,17
 
 
 
A pyrene fluorescence probe revealed that structural differences between early (G < 
3.5) generations and late (G > 4.5) generation of PAMAM dendrimers exist.19  The early 
generations tend to be more hydrophilic in nature with a large separate between the 
surface groups (Figure 1.4).  The later generations are more hydrophobic and are more 
densely packed (Figure 1.4).  Electron paramagnetic resonance (EPR) studies using Cu 
(II) or nitroxide complexes with PAMAM dendrimers support evidence found from 
fluorescence studies.20,21  In these studies, the probe was able to move freely in early 
generation PAMAM dendrimers.  This free moving behavior was indicative of an 
extended structure.  The probe’s motion was slower because of the dendrimer’s more 
compact structure. 
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Figure 1.4.  Density of packing between ‘early’ generation PAMAM dendrimers and 
‘late’ generation PAMAM dendrimers. 
 
 
 
Chen and co-workers were able to demonstrate that changing the pH of the solution; 
a conformational change can be induced.22  The polarity of the dendrimer was decreased 
in basic pH (> 8.3) environments.  The authors concluded that this decrease in polarity 
suggested backfolding of the dendritic termini.  As the pH was lowered, the polarity of 
the dendrimer increased.  The interior nitrogens were assumed to become protonated 
causing charge-charge repulsion, expanding the molecule.  More recently, MD 
simulation by Maiti et al described backfolding to be present at high and low pH.23  The 
simulation also provided evidence that PAMAM swells to a larger radius of gyration in 
solvent when compared to no solvent present in the simulation.  In agreement with 
Chen’s pH study, the simulation did show that charge repulsion extends various 
branches out towards the periphery of the molecule. 
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Poly(aryl ether) or Fréchet-type Dendrimers 
In addition to PAMAM dendrimers, polyarylether dendrimers have also been 
examined. Mourey et al. studied polyaryl ether dendrimers using size exclusion 
chromatography and differential viscometry (Figure 1.5).24  The polyarylether 
dendrimers had hydrodynamic radii that increased linearly as a function of molecular 
weight and a maximum in the intrinsic viscosity as a function of molecular weight was 
found.  According to the authors, the data suggested the structures expanded to 
approximately two-thirds their theoretical extended length.  De Backer and co-workers 
observed through fluorescence depolarization measurements that the dendrimer 
conformation can change by varying the solvent (Figure 1.5).25  A more extended 
structure was observed for the dendrimer in medium to good solubilizing solvents 
(acetone and toluene, respectively).  In a poor solubilizing solvent such as acetonitrile, 
the hydrodynamic volume of the dendrimer decreased significantly, suggesting a more 
compact structure.  The studies of Mourey and De Backer are in qualitative agreement 
with the theoretical study of Lescanec and Muthukumar8 in which the end groups can be 
found throughout the dendrimer volume, i.e. backfolding occurs.  De Backer’s study also 
correlated well with of Murat and Grest12 in which solvent can change the 
conformational behavior of the molecule. 
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Figure 1.5.  Polyarylether dendrimers studied by Wooley24,26 (a) and De Backer25 (b). 
 
 
 
Backfolding in the solid-state was observed by Wooley et al using rotational-echo 
double-resonance (REDOR) NMR.26  The core of the polyarylether dendrimer was 19F 
labeled and the periphery was 13C labeled.  Dipolar coupling between 13C-19F was used 
to determine that the periphery groups were backfolding.  Increasing the generation 
number decreased the dipolar coupling, suggesting a decrease in interpenetration of the 
peripheral groups to the core.  Additionally, Gorman and co-workers were able to 
establish that the end groups of Fréchet-type dendrimers come in close proximity to the 
core.27  Two sets of Fréchet-type dendrimers, G1-G3, were used:  one with a 
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diamagnetic core and the other with a paramagnetic FeS core (Figure 1.6).  A noticeable 
shortening of the spin-lattice relaxation (T1) times of various protons of the paramagnetic 
core dendrimer was observed when compared to the diamagnetic core dendrimer.  The 
shortening of T1 was attributed to each layer of the molecule coming in close contact 
with the paramagnetic core, i.e. backfolding was occurring.  Backfolding was attributed 
to be the major cause of the very rapid electronic energy transfer in polyaryl ether 
dendrimers.28   
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Figure 1.6.  G2 examples of paramagnetic and diamagnetic core Fréchet-type dendrimers 
studied by Gorman.27
 
 
 
Poly(propyleneimine) Dendrimers 
Small-angle neutron-scattering (SANS) and viscometry measurements of both nitrile 
and amine terminated poly(propylene imine) (PPI) dendrimers by Scherrenberg and co-
workers found a linear relationship between the radius of the dendrimer and its 
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generation number.29  This linear relationship was independent of the type of end group 
or solvent used.  These results correlate well with the theoretical results of Murat and 
Grest12 indicating that PPI dendrimers are flexible with a relatively uniform density 
distribution resulting from some degree of backfolding.  An extensive SANS study by 
Vögtle and co-workers demonstrated that the peripheral groups of the dendrimer are 
dispersed throughout the dendrimer (Figure 1.7).30  A maximum density was located in 
the center of the molecule, suggesting the end groups are backfolded.  This supports the 
dense-core model of Boris and Rubinstein.9 
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Figure 1.7.  Examples of PPI dendrimers.  a) G4 PPI dendrimer studied by Vogtle.30  b) 
G5 PPI dendrimer (‘Dendritic Box’) studied by Meijer.31,32  c) Amphiphilic PPI 
dendrimer studied by Ford.36
 
 
 
The ‘dendritic box’, Figure 1.7,  synthesized by Jansen et al. takes advantage of the 
end group backfolding to encapsulate guest molecules.31,32  Spin-lattice (T1) and spin-
spin (T2) relaxation experiments showed that the higher generation dendrimers were 
tumbling more slowly than the lower generation derivatives.  Crystal data later provided 
direct evidence of the end groups backfolding via hydrogen-bond interactions.33  
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Secondary interactions such as hydrogen-bonding were attributed to the backfolding of 
the peripheral groups. 
Through the use of a high field spectrometer, Chai and co-workers were able to 
perform an extensive NMR study of PPI dendrimers finding evidence for backfolding 
using 2D NOESY.34,35  Two-dimensional NOESY studies of PPI dendrimer and solvent 
were performed to study the interpenetration of solvent with the dendritic volume.  
Benzene was found to be excluded from the dendrimer interior, while chloroform was 
found to interpenetrate the dendritic volume, thus creating a solvent poor and solvent 
rich environment, respectively.  Studying the interactions of the dendritic arms in the 
two solvents showed a difference in conformation.  In benzene solution, the arms tended 
to backfold, while in chloroform solution nOes were not observed between the dendritic 
arms suggesting an extended structure was induced.  Similar conclusions were observed 
by Pan and Ford studying the 13C T1 times of a PPI dendrimer with both hydrophilic and 
hydrophobic end groups.36  In polar solvent, such as methanol, the hydrophilic arms 
moved more freely, while the hydrophobic arms moved more slowly.  The reverse was 
true in a more nonpolar solvent such as chloroform. 
Secondary Interactions 
To study the secondary interactions of the peripheral groups, VT coefficients and 
hydrogen/deuterium (H/D) exchange studies have been performed.33,37,38  Variable 
temperature coefficients of a G1 PPI dendrimer provided evidence that the terminal 
groups were backfolding.33  Higher-order secondary interactions did not exist in β-
alanine dendrimers studied by Mong et al (Figure 1.8).37  They came to this conclusion 
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by observing that the coefficients were more negative than -4 ppb/K, the threshold for 
observing secondary interactions.  The VT studies were able to show that the inner most 
NHs were less exposed to solvent than the peripheral NHs of the molecule.  
Hydrogen/deuterium exchange supports this conclusion.  The rate of exchange was 
enhanced when the NHs were ‘dendronized’.  Comparison of model compounds and the 
dendrimer showed a large decrease in the exchange rate.  The glutamic acid dendrimers 
studied by Appoh and co-workers showed strong H-bond interactions based on 
temperature coefficients (Figure 1.8).38  The coefficients were similar at both high and 
low concentrations suggesting intramolecular hydrogen-bonding.  Their NMR results 
were supported by IR investigations with the glutamic acid dendrimers. 
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Multi-dimensional NMR techniques have been used to characterize dendrimers, 
determine their conformation and to observe host-guest interactions within them.  To 
evaluate host-guest interactions, Morgan et al.,39 Banerjee et al.40 and Broeren et al.41 
(Figure 1.9) used 2D NOESY to confirm that the guest molecule was interacting with the 
dendrimer.  Meijer’s dendritic box was one of the first examples of the physical 
encapsulation of guest molecules by a dendrimer.31,32  An NMR study by Morgan et al. 
showed that a G4 poly(glycerol succinic acid) dendrimer could encapsulate of 
Reichardt’s dye (Figure 1.9).39  Comparison of the proton spectra of the free dye in 
solution to that of the encapsulated dye showed distinct broadening of the NMR 
resonances.  The T1 and T2 relaxation of the dye also decreased significantly, suggesting 
encapsulation by the dendrimer.  A 2D NOESY spectrum provided nOes between the 
dye and dendritic arms.  Multi-dimensional NMR experiments showed that a guest 
molecule could bind to targeted binding sites on a PPI dendrimer.40  More recently, 
heteronuclear NMR techniques were used to prove that the guest binds not only to the 
targeted binding sites but many other sites within the PPI dendrimer.41
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Conclusions 
Conformational analysis of various dendrimer systems has been well studied through 
the use of many techniques.  Many of these studies suggest that the dendritic arms 
backfold to some extent when high generations are achieved.7-10,13-15,19-21  Several 
experimental studies, including simulations, have suggested that the conformation of the 
dendrimer can be changed either through a change in solvent, pH or ionic 
concentration.8,11-14,22,23,25,35,36  This dissertation attempts to describe the conformational 
analysis of a triazine-based dendrimer using various NMR techniques.  The goals of 
these studies are to confirm many of these observations in a single dendrimer system and 
elaborate on more subtle issues of conformation. 
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CHAPTER II 
IDENTIFICATION OF DIAMINE LINKERS AND THEIR APPLICATION IN 
THE SYNTHESIS AND CHARACTERIZATION OF A MELAMINE 
DENDRIMER BEARING UNIQUE NMR SIGNALS* 
 
Introduction 
Our group has invested significant energies in the synthesis of dendrimers based on 
triazines, also referred to as dendrimers based on melamine deriving from our use of 
diamine linkers.42,43  Our early targets commonly incorporated p-aminobenzylamine 
because of the significant differences in the reactivity of the amines of this group.  That 
is, during a convergent synthesis, protecting group manipulations and functional group 
interconversions could be avoided because the benzylic amine would react preferentially 
(essentially exclusively) with the monochlorotriazine dendron being elaborated.42,44-48  
The low stability of these aniline derivatives required reasonable, but additional, care on 
handling.  While dry distilled solvents, inert atmospheres and refrigerated storage are 
commonplace, we recognized that these liabilities could impact the broader acceptance 
of these materials.  The low cost and high reactivity of piperazine soon made it a linking 
diamine of choice for our investigations.  However, when using piperazine, dimerization 
of monochlorotriazines was observed under non-ideal reaction conditions that were 
usually attributed to concentration, rate of addition, ineffective stirring or lack thereof,  
____________ 
*Reproduced with permission from Moreno, K.X., Simanek, E.E. Macromolecules, 
submitted for publication.  Unpublished work copyright 2007 American Chemical 
Society. 
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temperature of addition and the magnitude of stoichiometric excess.45,49-59  Reactions 
with either p-aminobenzylamine or piperazine could be readily followed by NMR.  The 
shift of the benzylic protons on reaction with the monochlorotriazine dendron or the 
desymmetrization of the piperazine group was diagnostic, although in the latter case, 
dimerization was often impossible to detect by NMR unless it occurred to the extent that 
the methylene groups of the desymmetrized product showed markedly different 
integrations.   
The wealth of commercially available diamines led us to conduct a rational survey of 
reactivity with the expectation that linkers possessing reactivity differences displayed in 
p-aminobenzylamine without the disadvantages previously described.  Asymmetric 
diamines that unambiguously revealed undesired dimerization events were also desired.  
Our original study examined a range of primary and secondary amines including the 
cyclic amines piperidine and two piperazine derivatives (A-F, Figure 1).  From these 
studies, aminomethylpiperidine emerged as a diamine linker of choice and was used 
extensively.42,43,48,50,56-58,60,61  The relative reactivity difference measured for the cyclic 
secondary amine and primary amine is ~ 20 based on competition experiments.  
Theoretically, 5% of the product formed might derive from reaction of the 
monochlorotriazine dendron with the primary amine instead of the desired secondary 
amine.  As this population difference approaches the limit of detection by NMR 
spectroscopy, the efforts described here were undertaken to identify other suitable 
diamine linkers.  These amines are identified as G-K in Figure 2.1. 
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Figure 2.1.  Relative reactivity map for the substitution of monochlorotriazines.  The 
reactivity difference between consecutive amines is shown on the scale. 
 
 
 
The diamine linkers identified from the relative reactivity data were incorporated 
into a dendrimer as a proof-of-concept.  However, during the course of the synthesis, it 
became clear that these linkers displayed unique signatures in the 1H NMR spectra.  This 
observation suggested that in addition to routine analyses that are especially useful 
during the step by step synthesis of dendrimers, the incorporation of these diamines 
allowed the core, the middle ‘layer’, and the periphery to be uniquely identified 
throughout the dendrimer.  There is limited precedent for this level of characterization.  
Using  aliphatic polyesters, Ihre estimated the hydrodynamic radii utilizing molecular 
self-diffusion studies by pulsed field spin echo 1H NMR.62  Gorman used paramagnetic 
and diamagnetic polyaryl ether dendrimers to illustrate backfolding of the end groups 
utilizing spin-lattice relaxation measurements.27  Lellek and Stibor used binap 
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derivatized dendrimers to probe how chiral groups affect the conformation of the 
dendrimer and their feasibility for use in catalysis.63  Seebach reported on the synthesis 
and properties of multiple diastereomeric polyaryl ether dendrimers.64  Rinaldi was able 
to observe unique NMR signals for poly(propylene imine) (PPI) dendrimers from core to 
periphery using a high–field spectrometer.35  Meijer and co–workers were able to 
observe the resonances of different nitrogens, by 15N NMR, of PPI dendrimers from core 
to periphery at natural abundance.65  Given the power of multidimensional NMR, we 
hypothesized that additional structural information might result if the dendrimer could be 
adequately characterized.  This chapter concludes with the characterization of the 
generation three dendrimer that results from the utilization of these diamines and the 
assignment of its NMR spectrum.  The following chapter addresses the conformational 
analysis of the molecule. 
Results and Discussion 
Previously, the relative reactivity data of various amines (A – F) towards a 
monochlorotriazine DMTA (Figure 2.1) was determined and used to identify diamine 
linkers for dendrimer synthesis.42  Here, expansion of this data included the relative 
reactivity of various cyclic amines (G – K) towards DMTA.  The competition studies 
were carried out in a manner identical to our original protocol:  three equivalents of each 
amine competed for reaction with DMTA.42  To faciliate comparison of G-K to A-F 
(published previously), we used both A and F in these reactivity studies.  The reactivity 
map was obtained by determining the product ratios using 1H NMR after disappearance 
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of DMTA.  These values for individual competition studies are consistent 
multiplicatively across the range of amines within experimental error. 
The data show that as ring size decreases, the reactivity of the amine increases.66  
The most reactive amines (G, H, and A) have pKas of 11.3, while the less reactive 
amines (I-K) have pKas of 10.8.67,68  Sterics can be used to rationalize the difference in 
reactivity within these subgroups. 
From this data, diamine linkers can be identified.  These linkers were chosen based 
on three criteria:  1) a minimum reactivity difference of ~ 20 between the amines is 
desired in order to keep the number of side products to a minimum, 2) one or more 
unique 1H NMR signals for characterization during synthesis, and 3) commercial 
availability or accessibility in a minimal number of steps.  Diamine linkers L1–3 (Figure 
2.2) were chosen because they meet the criteria and are commercially available.  A 
single enantiomer of 2-aminopyrrolidine was used. 
 
 
~ 180~ 20~ 70
L1 L3L2
NHH2NNHNH
H2N
H2N
 
Figure 2.2.  Diamine linkers chosen for dendrimer synthesis.  Reactivity difference 
between amines shown below each linker. 
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Figure 2.3.  Synthesis of G3 dendrimer, 2.8.  a) THF, rt, 14h. b) THF, cyanuric chloride, 
Hunig’s Base (DIPEA), 40 oC, 14h. c) THF, rt, 14h. d) THF, cyanuric chloride, Hunig’s 
Base (DIPEA), 40 oC, 2d. e) THF, 2.7, BEMP resin, 70 oC, 7d. f) THF, cyanuric 
chloride, Hunig’s Base (DIPEA), 70 oC, 7d. g) (1:1) TFA:DCM, rt, 14h. 
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Synthesis 
Figure 2.3 shows the convergent strategy used to synthesize dendrimer 2.8.  
Following selective protection of the primary amines of 3,3’–diaminodipropylamine 
with BOC–ON, treatment with cyanuric chloride affords monochlorotriazine 2.1.  
Intermediate 2.1 is treated with an excess of L1 to produce 1.2.  In an iterative fashion, 
the synthesis continues with reaction of cyanuric chloride to form 2.3, then L2 to 
generate 2.4.  Cyanuric chloride treated with a slight excess of 2.4 gives 2.5.  While 
iteration with 2-aminoazetidine progresses the sequence, sterics precludes trimerization 
with a cyanuric chloride core.  Instead, a less sterically encumbered core, 2.7, is 
synthesized by treating cyanuric chloride with L3 followed by deprotection.  This 
strategy affords a highly reactive core possessing three azetidine groups which yield 
dendrimer, 2.8, after reaction with a large excess of 2.5.  The reported yield represents 
the amount of material obtained in pure form after extensive chromatography, and is not 
a reflection of an unsuccessful reaction.  Indeed, we estimate conversion to product 
occurred in >80%. 
NMR Characterization   
Dendrimer 2.8 contains nineteen unique protons in DMSO-d6 at room temperature.  
The magnitude of the NMR signal reflects the location of the group; groups on the 
periphery are present in larger number than those on the core as a result of the 
exponential growth of the dendrimer.  Complete assignment of the resonances is difficult 
based on simple inspection of a spectrum.  Complete and unambiguous assignment 
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required both model compounds, and HMQC69 and COSY70 correlations.  The data of 
Figure 2.4 is representative. 
 
 
 
 
Figure 2.4.  (1H–1H) TOCSY spectrum of 2.8 in DMSO-d6 at 75 oC. 
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Figure 2.5  Model compounds used for assignment of NMR spectra of dendrimer 
intermediates. 
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The model compounds used to corroborate assignment are shown in Figure 2.5.  
These particular compounds, 2.9-2.14, were chosen to provide insight into the position 
of the chemical shift for various protons of each linker.  The diethylamino substituent 
was chosen due to its beneficial impact on solubility, NMR signatures, and symmetry 
which precludes the existence of rotamers that would have resulted had ethylamino 
groups been used.  Proton spectra for each linker and comparison with the appropriate 
intermediate are found in Appendix A.  All NMR spectra were taken in DMSO-d6 for 
three reasons:  1) to observe the NH signals downfield from the rest of the resonances, 2) 
to sharpen the spectrum of the dendrimer in chloroform was very broad and complex 
with the NH signals upfield, and 3) the dendrimer did not show structural biases in 
deuterated methanol or chloroform.   The discussion of the NMR spectra is divided into 
two parts.  The first part addresses the upfield region of the spectra between 0.5 ppm and 
5 ppm. The second part describes the exchangeable NH region of the spectra between 
6.0 ppm and 8.5 ppm. 
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Figure 2.6.  1H NMR spectra (0.5 – 5.0 ppm) of intermediates 2.1-2.6 and dendrimer 2.8.  
Lines that shift as a result of the synthesis are reassigned in subsequent spectra.  All 
spectra taken in DMSO-d6 at 25 oC.  Omitted letters correspond to carbon atoms that do 
not bear hydrogen atoms. 
 
 
 
The Upfield Region of the Spectra.  Assigning the upfield region of the spectra is 
challenging due to broad lines and similar chemical shifts.  However, the systematic 
appearances of lines, shifts of certain lines downfield upon reaction, and disparity in 
chemical shifts between axial and equatorial ring protons allows us to step through these 
spectra with an assignment that is ultimately corroborated by 2D NMR techniques and 
model compounds.  These trends are shown in Figure 2.6.  The discussion of these 
spectra is divided by linking diamine or group. 
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The Surface BOC group.  Resonances corresponding to the BOC-protected triamine 
surface groups, HA,D–F, are a dominating feature of all the spectra.  These resonances 
show little change in chemical shift over the course of the synthesis.  While rotamers do 
not exist based on symmetry, slow rotation around the triazine-N bond make both 
environments of the surface group unique in the expected 1:1 ratio.  These two 
environments are most discernable in the spectrum of monochlorotriazines, a feature that 
we attribute to the inductive effects of the chlorine atom giving rise to greater double 
bond character in the triazine-N bond.  On replacement of chlorine with an amine linker, 
the lines no longer appear distinct (instead, a broad peak) except for the protons most 
sensitive to the two environments, HF. 
The Aminopyrrolidine Linker.  Intermediate 2.2 introduces pseudo-axial and pseudo-
equatorial resonances, the latter of which more downfield than the former by ~0.5ppm.  
Protons adjacent to a nitrogen atom appear between 3.2 and 3.6 ppm (HI’ and HL’ 
overlap at 3.6 ppm, HL and HJ overlap at 3.45 ppm, HI appears at 3.2 ppm), while the 
aliphatic methylene resonances, HK,K’, have chemical shifts of 1.6, and 1.9 ppm, 
respectively.  For 2.3, most of the pyrrolidine protons are shifted downfield.  Protons 
HJ,L’,I’,K’,K can be unambiguously assigned separately from the rest of the resonances; 
the remaining resonances of the pyrrolidine ring, HL,I, overlap at 3.4 ppm with the HF 
resonance of the peripheral group.  The existence of rotamers is seen for HI’ first in 2.3, 
and then HJ protons in 2.4, but increasing broadness of lines precludes any discussion of 
changing rotamer populations based on these peaks alone.  As expected the chemical 
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shift of HJ shifts downfield by almost 1 ppm on substitution of the chlorine atom for a 
linking diamine.   
The Aminopiperidine Group.  The trends observed in the linker are more pronounced 
in the aminopiperidine group.  Axial and equatorial protons of a methylene show greater 
differences in chemical shift.  Protons adjacent to an amine (HO,O’,Q) appear more 
downfield than more aliphatic methylenes HP,P’.  Upon substitution of the chlorotriazine, 
HQ shifts ~1 ppm downfield.  Broad lines are suggestive of rotamer populations, but 
these cannot be unambiguously identified from this region of the spectrum.   
The Core.  The spectrum of the protected core, 2.6, reveals rotamers that become less 
evident in this region of the spectrum for the final dendrimer.  Both the pseudo-axial and 
pseudo-equatorial protons of the azetidine ring can be distinguished and the protons 
proximate to the nitrogen see a more pronounced change in chemical shift on reaction 
that results from the attachment of a triazine ring. 
Total correlated spectroscopy (TOCSY) correlations of 2.8 confirms the assignment 
(Figure 2.4).  The cross-peaks between the 1-5 ppm (CH) region and 5-8 ppm (NH) 
region of the spectrum indicate protons common to a correlated spin system, or linking 
diamine.  The only protons not correlated to any spin system are those of the tert-butyl 
protons of the surface group, HA.  The spectrum shows the three methylene resonances 
and one carbamate resonance for the surface group (red), the seven CH resonances and 
one NH resonance for the pyrrolidine ring (green), the five CH resonances and one NH 
resonance of the piperidine ring (maroon), and the three CH resonances and one NH 
resonance of the azetidine ring (blue). 
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The Exchangeable NH Region of the Spectra.  The region of the 1H NMR spectra 
between 6 and 8.5 ppm displays a significant amount of structural complexity 
commencing with the NH protons of the carbamate group of intermediate 2.1 which 
appear as two discernable sets of peaks labeled in red as NHBOC (Figure 2.7).  We 
attribute this complexity to the anti and syn conformation of the carbamate group.71  The 
complexity of NH region increases with the incorporation of the pyrrolidine group of 2.2 
as the set of NH peaks increases from two to at least three in a ratio of 8:7:1 (downfield 
to upfield).  The complexity may arise from issues surrounding slow rotation around C-
N bonds of both the carbamate group and the triazine-amine group.  An exact 
assignment of these lines has not been made.  This complexity is unaffected upon 
subsequent iteration to 2.3.  The NH2 group of 2.2 is not observed in these spectra; it is 
expected upfield.  The pyrrolidine region of 2.3 displays at least three peaks in a ratio of 
13:6:1.  These peaks are attributed to the existence of rotamers as shown in Figure 2.8.  
We have applied a local stereochemistry approach to describe the triazine rotamers using 
the E,Z nomenclature of amides (Figure 2.8).72,73   
Studies of atrazine reveal the barrier for interconversion is 16.5 kcal/mol in aprotic 
solvent with relative populations of the rotamers as 5(EEt,EiPr): 3(ZEt,EiPr): 3(EEt,ZiPr): 
1(ZEt,ZiPr) (Figure 2.8).74,75  According to the atrazine studies, the E,E rotamer is the 
most downfield and the Z,Z rotamer is the most upfield.  By extrapolation, we assign the 
E,E rotamer as the major isomer in 2.3.  The carbamate moiety in 2.3 displays an NH 
ratio of 9:8:1, an insignificant change in populations from 2.2. 
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Figure 2.7.  1H NMR spectra (6.0 – 9.0 ppm, NH region) of intermediates 2.1-2.6 and 
dendrimer 2.8.  Lines that shift as a result of the synthesis are reassigned in subsequent 
spectra.  All spectra taken in DMSO-d6 at 25 oC. 
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Figure 2.8.  Rotamers of the pyrrolidine, piperidine and azetidine groups.  Rotamers of 
atrazine shown with rotameric ratio below each rotamer. 
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Iteration of 2.3 to 2.4 reveals the pyrrolidine NHs shift upfield.  Substitution of the 
chlorine atom by 4-aminopiperidine removes the deshielding effects the chlorine had on 
the pyrrolidine NH.  The NH2 of 2.4 is not observed in these spectra, it is expected 
upfield.  The three major resonances of the carbamate moiety remain but with a slight 
increase in the two main populations, 12:10:1.  Spectra show that only one pyrrolidine 
NH is observed.  A COSY spectrum identifies one pyrrolidine NH resonance buried 
under the most downfield carbamate NH resonance at 6.70 ppm.  This could explain the 
slight increase in the carbamate NH populations. 
Intermediate 2.5 provides another layer of complexity to the rotamer populations.  
The carbamate NH populations remain largely unchanged.  The ratio of 7:6:1 falls 
within the percentage previously seen in 2.2 and 2.3 but not 2.4, supporting our belief 
that the slight increase in the population from 2.4 was the result of overlap of the 
pyrrolidine NH.  Two pyrrolidine NH resonances attributed to the (E,E) and (E,Z) 
conformations can be identified in a ratio of 2.5:1.  We presume that the (Z,Z) rotamer 
exists below the limits of detection for the spectrometer:  it was not observed in the 
COSY spectrum.  The appearance of the five isomers of piperidine in 2.5, adds the most 
complexity to this discussion.  Although we were unable to assign rotamers to these 
resonances, COSY crosspeaks verify the resonances as piperidine NHs.  The five sets of 
peaks suggest that the isomerism and conformational preferences are being 
communicated through the dendrimer as is seen with Parquette’s systems, or that 
additional sources of isomerism (i.e. ring conformations) are emerging. 
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Analysis of the spectrum of 2.6 shows four sets of resonances for the azetidine NH 
(Figure 2.7) in a 1:1:1:1 ratio.  Figure 2.8 displays two primary rotamers for this 
molecule.  Subsequent reaction of the core with 2.5 forms 2.8.  In 2.8, the broadness of 
the azetidine NHs precludes us from obtaining a reliable population ratio.  Through the 
use of a TOCSY76 spectrum, we were able to confirm that indeed the azetidine NHs 
were present.  The ratio for the pyrrolidine NHs in 2.8 changes significantly from those 
observed for 2.3-2.5.  The rotamer population shifts to favor the (E,Z) rotamer, 6.77 
ppm, over the (E,E) rotamer, 6.90 ppm, in ratio of 1.3(E,Z):1(E,E).  The (Z,Z) rotamer 
was not observed in the TOCSY spectrum of 2.8.  The remaining NHs resonances have a 
ratio of 9:9:1.  Though the majority of the population belongs to the carbamate NH, the 
piperidine NH is also overlapped within these resonances.  This precludes us from 
identifying how the dendrimer affects the piperidine NH populations.  Regardless, this 
final observation is significant as it supports the emergence of peripheral crowding of 
surface groups and emergence of a “globular” or “hard sphere” architecture. 
Conclusions 
With the use of competition studies, we have been able to quantify the relative 
nucleophilicity of amines towards a model monochlorotriazine effectively expanding our 
range to 320x.  From these data, three new diamine linkers were designed and used to 
synthesize a melamine dendrimer. Each linker offers interesting features that can be 
exploited in future work.  Aminoazetidine (L1) offers a highly reactive and sterically 
unencumbered amine that might find use in situations where piperidine-type amines are 
unreactive or sluggish.  Aminopyrrolidine (L2) offers opportunities to explore chiral 
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environments in these dendrimers.  Aminopiperidine (L3) offers an inexpensive linker 
that aligns with our current reliance on aminomethylpiperidine groups.  In addition, 
these linkers convey spectroscopically unique signatures to different regions of the 
dendrimer architecture; an effect only rarely observed in related architectures.27,35,62-65   
While a more rigorous discussion of conformational analysis of this dendrimer is 
presented in the following paper, clues from these 1D spectra provide preliminary 
insight into structure.  The complexity of the NH-region of the spectra and broad 
features observed in upfield lines suggests that a rich population of rotamers exists.  
Through the iteration of the dendrimer synthesis, the carbamate NH populations do not 
change.  The most significant changes were observed from the pyrrolidine NH 
populations.  An initial 2:1 ratio of (E,E):(E,Z) expected for a conformationally 
unhindered molecule shifted a 1:1.3 ratio indicative of a sterically congested 
architecture.   
Experimental Section 
Chemicals were purchased from Aldrich and Acros and used without further 
purification.  All solvents were ACS grade and used without further purification.  NMR 
spectra were recorded on an Inova 500 MHz spectrometer in CDCl3 or DMSO–d6.  All 
mass spectral analyses were carried out by the Laboratory for Biological Mass 
Spectrometry at Texas A&M University. 
2D TOCSY NMR.  The 1H–1H TOCSY76 spectra were performed using the same 
500 MHz spectrometer.  The data was collected using a π/2 pulse width of 7.3 μs, a 
relaxation delay of 10 s, 4.5 kHz spectral window and 0.228 s acquisition time; a spin–
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lock pulse was applied for a period of 0.046 s with a spin–lock field of 5.4 kHz with 
MLEV–17 modulation; 16 transients were averaged for each of the 2 x 256 increments 
using the States method77 of phase sensitive detection.  The data were zero–filled to a 
1024 x 1024 data matrix before Fourier transformation. 
Typical competition reaction.  Pyrrolidine (107 mg, 1.5 mmol) and piperidine (128 
mg, 1.5 mmol) were added to a vial with THF (10 mL).78  To this solution dimorpholino-
monochlorotriazine (DMTA, 143 mg, 0.5 mmol) was added and the reaction was left to 
stir for 18 hr.  TLC confirmed the absence of DMTA for all reactions.  The solvent was 
then removed and the residue was passed through a silica gel column containing 
DCM:Methanol (9:1) to remove excess amines.  Fractions containing UV-active material 
that were not positive to ninhydrin staining (those excluding benzylic amines) were 
combined and analyzed using 1H NMR. 
Dimorpholino-monochlorotriazine (DMTA).  To a solution of cyanuric chloride 
(10.3 g, 55.8 mmol) in THF  (250 mL) at 0 oC, morpholine (9.70 mL, 111 mmol) and 
Hunig’s base (20.0 mL, 115 mmol) were added.  After six hours, the solution was 
filtered and the solvent removed.  The crude product was dissolved in hot methanol and 
precipitated by cooling.  The product was reprecipitated from methanol again yielding a 
white solid (12.6 g, 79 %).  1H NMR (300 MHz, CDCl3, δ):  3.78 (br m, 8H), 3.70 (t, J = 
4.95 Hz, 8H).  13C NMR (75 MHz, CDCl3, δ):  171.4, 164.7, 66.9, 44.1; MS (ESI) mass 
calc’d for C16H33N3O4 = 285.73; found 286.3 [M+H]+. 
Bis(3-BOC-3-aminopropyl)amine.  A solution of BOC-ON (2-(tert-
butoxycarbonyloxyimino)-2-phenylacetonitrile) (40.11 g, 162.9 mmol) in THF (320 mL) 
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was added drop wise over a period of 2 h to an ice – bath cooled solution of bis(3-
aminopropyl)amine (11.62 mL, 81.47 mmol) and Hunig’s base (43.0 mL, 247 mmol) in 
THF (65 mL).  The reaction warmed to room temperature over a period of 4 h.  The 
solvent was subsequently removed by reduced – pressure evaporation.  The yellow – 
green liquid residue was dissolved in DCM and washed with three portions of 5% (w/v) 
NaOH.  The organic layer was dried over MgSO4, filtered, and the solvent removed by 
reduced – pressure evaporation to give thick clear oil.  The product was precipitated 
from petroleum ether to give a white solid (22.85 g, 84.6 %).  1H NMR (300 MHz, 
CDCl3, δ):  5.3 (brs, NH), 3.16 (br m, 4H), 2.61 (t, J = 6.6 Hz, 4H), 1.61 (m, 4H), 1.4 (s, 
18H); 13C NMR (75 MHz, CDCl3, δ):  156.4, 79.2, 47.6, 39.0, 29.9, 28.6.  MS (ESI) 
mass calc’d for C16H33N3O4 = 331.45; found 332.26 [M+H]+. 
Intermediate 2.1.  A solution of bis(3-Boc-3-aminopropyl)amine (12.3 g, 37.1 
mmol) and Hunig’s Base (20 mL, 115 mmol) in THF (100 mL) was added to a solution 
of cyanuric chloride (3403 mg, 18.45 mmol) in THF (30 mL) at room temperature.  
After stirring overnight, the solvent was removed by reduced pressure evaporation to 
give an oil.  The oil was dissolved in 70 mL DCM and washed with three 70 mL 
portions (5 %) HCl solution, four 70 mL portions (5 %) NaOH solution, and three 70 mL 
portions of brine solution.  The organic layer was dried over MgSO4 and filtered.  The 
solvent was removed from the filtrate to give off-white colored foam.  The foam was 
dissolved in DCM and a silica gel column was performed using a DCM:Methanol (50:1) 
solvent system.  Fractions containing product, as determined by TLC, were combined 
and had their solvent removed by reduced pressure evaporation to give white foam 
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(10083.6 mg, 70.6 %).  1H NMR (500 MHz, DMSO-d6, δ):  6.8 (m, NH), 3.42 (t, J = 7.0 
Hz, 8H), 2.92 (m, 4H), 1.64 (m, 4H), 1.4 (s, 36H).  13C NMR (125 MHz, DMSO-d6, δ):  
169.1, 164.7, 156.5, 156.4, 78.4, 78.4, 55.8, 45.9, 45.3, 38.8, 38.4, 29.2, 28.9, 28.6; MS 
(ESI) mass calc’d for C35H64ClN9O8 = 774.39; found 774.48 [M+H]+. 
Intermediate 2.2.  A solution of 2.1 (10.262 g, 13.251 mmol) in THF (50 mL) was 
added dropwise to a solution of R-3-aminopyrrolidine (2.60 mL, 29.7 mmol) in THF (10 
mL) at room temperature.  After stirring overnight, the solvent was removed by reduced 
pressure evaporation to give red foam.  The foam was dissolved in DCM and passed 
through a silica gel column using DCM:Methanol (19:1).  Fractions containing product, 
as determined by TLC, were combined and solvent removed yielding pale yellow foam 
(10.32 g, 94.5 %).  1H NMR (500 MHz, DMSO-d6, δ):  6.7 (br m, NH), 6.4 (br s, NH), 
3.32-3.59 (br m, 12H), 3.15 (m, 1H), 2.92 (m, 8H), 1.96 (m, 1H), 1.64 (m, 9H), 1.4 (s, 
36H).  13C NMR (125 MHz, DMSO-d6, δ):  165.2, 164.1, 156.5, 78.4. 54.2, 51.3, 44.9, 
44.7, 44.6, 38.9, 38.7, 38.4, 34.3, 29.3; MS (ESI) mass calc’d for C35H64ClN9O8 = 
823.56; found 824.59 [M+H]+, 312.74 [M+2H]+2, 262.71 [M+2H]+2, 212.68 [M+2H]+2. 
Intermediate 2.3.  A solution of 2.2 (5.95 g, 7.22 mmol) and Hunig’s base (4.0 mL, 
23 mmol) in THF (30 mL) was added to a solution of cyanuric chloride (634 mg, 3.44 
mmol) in THF (5 mL) at room temperature.  The reaction was heated to 40 oC overnight. 
The solvent was removed by reduced pressure evaporation to give a pale yellow foam.  
The foam was dissolved in DCM and passed through a silica gel column using 
DCM:Methanol (30:1).  Fractions containing product, as determined by TLC, were 
combined and solvent removed yielding a pale yellow foam (5.373 g, 88.8 %).  1H NMR 
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(500 MHz, DMSO-d6, δ):  6.78 (br s, NH), 6.73 (br s, NH), 6.7 (br s, NH), 4.48 (br m, 
2H), 3.80 (br m, 2 H), 3.66 (br m, 2H), 3.4 -3.6 (br m, 24H), 2.96 (br m, 16H), 2.17 (br 
m, 2H), 1.94 (br m, 2H), 1.68 (br m, 16H), 1.4 (s, 36H), 1.36 (s, 36H).  13C NMR (125 
MHz, DMSO-d6, δ):  169.2, 168.7, 166.0, 165.2, 164.1, 156.5, 156.3, 78.4, 78.3, 51.2, 
50.9, 50.6, 50.5, 45.0, 44.6, 38.9, 38.6, 38.4, 31.5, 31.3, 29.2, 29.1; MS (MALDI) mass 
calcd for C81H144ClN25O16 = 1759.62; found 1760.21 [M+H]+, 1783.18 [M+Na]+, 
1799.15 [M+K]+, 1659.12 [M+H-Boc]+, 1560.04 [M+H-2 Boc]+, 1359.00 [M+H-4 
Boc]+. 
Intermediate 2.4.  A solution of 2.3 (7.00 g, 3.98 mmol) in THF (15 mL) was added 
dropwise to a solution of 4-aminopiperidine (1.26 mL, 12.0 mmol) in THF (5 mL) at 
room temperature.  After reacting overnight, the solvent was removed by reduced 
pressure evaporation and the residue passed through a silica gel column using 
DCM:Methanol (19:1).  Fractions containing product, as determined by TLC, were 
combined and solvent removed yielding white foam (6474.4 mg, 89.3 %).  1H NMR 
(500 MHz, DMSO-d6, δ):  8.20 (br s, NH), 8.08, (br s, NH), 7.80 (br s, NH), 6.72 (br s, 
NH), 6.63 (br s, NH), 6.38 (br s, NH), 4.45 (br m, 2H), 3.80 (br m, 1H), 3.75 (br m, 1H), 
3.63 (br m, 2H), 3.50 (br m, 2H), 3.41, (br m, 16H), 3.36 (br m, 2H), 2.93 (br m, 16H), 
2.16 (br m, 1H), 2.11 (br m, 1H), 1.65 (br m, 16H), 1.36 (s, 44H), 1.32 (s, 28H). 13C 
NMR (125 MHz, DMSO-d6, δ):  168.2, 167.8, 165.2, 165.0, 164.7, 164.2, 163.2, 155.5, 
155.4, 155.3, 155.1, 77.4, 77.3, 50.2, 49.9, 49.7, 49.5, 44.0, 43.6, 37.9, 37.6, 37.4, 30.6, 
30.3, 28.2, 28.1;  MS (MALDI) mass calcd for C86H155N27O16 = 1823.32; found 1824.00 
[M+H]+, 1845.97 [M+Na]+, 1861.94 [M+K]+, 1723.96 [M+H-Boc]+. 
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Intermediate 2.5.  A solution of 2.4 (5.28 g, 2.89 mmol) and Hunig’s base (1.5 mL, 
8.6 mmol) in THF (5 mL) was added to a solution of cyanuric chloride (243 mg, 1.31 
mmol) in THF (5 mL) at room temperature.  The reaction was heated to 40 oC and 
allowed to react for 2 days.  The solvent was removed by reduced – pressure evaporation 
and the residue was passed through a silica gel column using DCM:MeOH (25:1).  
Fractions containing product, as determined by TLC, were combined and solvent 
removed yielding a pale yellow foam (4.31 mg, 87 %).  1H NMR (500 MHz, DMSO-
d6, δ):  7.86 (br s, NH), 7.75 (br s, NH), 6.95 (br s, NH), 6.82 (br s, NH), 6.73 (br s, NH), 
6.67 (br s, NH), 6.64 (br s, NH), 6.38 (br s, NH), 4.56 (br m, 2H), 4.47 (br m, 2H), 4.39 
(br m, 2H), 3.94 (brs, 1 H), 3.77 (br m, 2 H), 3.71 (br s, 1 H), 3.62 (br m, 4H), 3.4 -3.6 
(br m, 40H), 2.91 (br m, 32H), 2.11 (br m, 4H), 1.89 (br m, 2H), 1.76 (br m, 2H), 1.62 
(br m, 33H), 1.35 (s, 92H), 1.31 (s, 52H).  13C NMR (125 MHz, DMSO-d6, δ):  165.6, 
164.2, 163.2, 155.6, 155.4, 155.1, 77.4, 50.7, 49.6, 49.1, 48.1, 47.7, 47.4, 44.0, 43.8, 
43.6, 41.4, 38.0, 37.6, 37.4, 31.0, 30.7, 28.2; MS (MALDI) mass calcd for 
C175H308ClN57O32 = 3758.13; found 3759.02 [M+H]+, 3780.95 [M+Na]+, 3795.93 
[M+K]+, 3657.97 [M+H-Boc]+, 3557.89 [M+H-2 Boc]+. 
Intermediate 2.6.  1-Boc-3-amino-azetidine (172 mg, 0.999 mmol) and Hunig’s 
base (DIPEA, diisopropylethylamine) (0.690 mL, 1.33 mmol) was added to a stirred 
solution of cyanuric chloride (61.4 mg, 0.333 mmol) in THF (2 mL) at room 
temperature.  The reaction was then heated to 70 oC for seven days.  The solvent was 
removed by reduced pressure evaporation and the residue passed through a silica gel 
column using (20:1:3) DCM:MeOH:Ethyl Acetate  to give a white solid (186.4 mg, 94.6 
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%).  1H NMR (500 MHz, DMSO-d6, δ):  7.3 (br m, NH), 4.45 (br m, 3H), 4.02 (s, 6H), 
3.74 (br m, 6H), 1.4 (s, 27H); 13C NMR (125 MHz, DMSO-d6, δ):  166.1, 165.9, 156.5, 
156.3, 79.4, 57.4, 56.6, 41.0, 29.0; MS (ESI) mass calc’d for C27H45N9O6 = 591.7; found 
592.37 [M+H]+, 614.33 [M+Na]+. 
Dendrimer (2.8).  One milliliter of a 1:1 mixture of DCM:TFA was added to a 
solution of 2.6 (54.0 mg, 0.0912 mmol) in DCM (1 mL).  After an hour, the solvent was 
removed by reduced pressure evaporation.  The residue was redissolved several times in 
a MeOH/triethylamine (TEA) solution and evaporated under reduced – pressure.  The 
residue was dissolved in THF (1.5 mL) followed by the addition of BEMP resin (0.508 
g, ~ 1.118 mmol).  A solution of 5 (3.67 g, 0.976 mmol) in THF (8.5 mL) was added.  
The slurry was heated to 70 oC and allowed to react for 7 days.  After 7 days, the 
reaction was allowed to cool and then filtered.  The filter cake was washed several times 
with THF to recover as much material as possible.  The solvent from the filtrate was 
removed by reduced – pressure evaporation and residue passed through a silica gel 
column using (25:1:10) CHCl3:MeOH:Ethyl Acetate (EtOAc).  Once the spot for 
compound 5 passed through, the solvent system was switched to (20:1:1) 
CHCl3:MeOH:EtOAc to collect product.  Fractions containing pure product, as 
determined by TLC, were combined and solvent removed to give white foam (378 mg, 
36.2 %).  1H NMR (500 MHz, DMSO-d6, δ):  7.37 (br s, NH), 7.18, (br s, NH), 6.89 (br 
s, NH), 6.71, (br s, NH), 6.62 (br s, NH), 6.37 (br s, NH), 4.56 (br m, 15H), 4.47 (br m, 
6H), 4.40 (br m, 6H), 4.11, (br m, 6H), 3.93 (br m, 6H), 3.77 (br m, 18H), 3.63 (br m, 
12H), 3.55 – 3.25 (br m, 120H), 2.91 (br m, 108H), 2.10 (br m, 12H), 1.88 (br m, 12H), 
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1.75 (br m, 12H), 1.63 (br m, 96H), 1.35 (s, 271H), 1.31 (s, 173H).  13C NMR (125 
MHz, CDCl3, δ):  165.9 (br), 165.3, 165.1, 164.8, 164.1, 156.2, 156.0, 79.3, 79.1, 78.9, 
52.0 (br), 50.1 (br), 48.3, 47.9, 44.1, 43.1 (br), 42.1 (br), 41.9 (br), 39.3, 38.2, 37.0 (br), 
36.6 (br), 32.4 (br), 31.9 (br), 28.6, 28.3, 27.9, 27.8;  MS (MALDI) mass calcd for 
C537H942N180O96 = 11449.44; found 11479.26. 
Bis(Diethylamino)-monochlorotriazine (BDMC).  To a solution of cyanuric 
chloride (4.04 g, 21.9 mmol) in THF (90 mL) at 0 oC, diethylamine (4.70 mL, 45.4 
mmol) and Hunig’s base (17 mL, 98 mmol) were added.  After an hour, the solution was 
allowed to warm to room temperature.  After 1 day, the solvent was removed by reduced 
– pressure evaporation leaving a yellow oil.  This oil was passed through a silica gel 
column using (10:1) Hexanes (Hx): EtOAc.  Fractions containing pure product were 
combined to a give a clear, colorless thick oil (5.54 g, 98 %).  1H NMR (500 MHz, 
CDCl3, δ):  3.55 (q, J = 7.1 Hz, 4H), 3.51 (q, J = 7.1 Hz, 4H), 1.15 (t, J = 7.1 Hz, 12H).  
13C NMR (125 MHz, CDCl3, δ):  169.1, 164.1, 41.8, 41.5, 13.5, 12.9; MS (ESI) mass 
calc’d for C11H20ClN5 = 257.14; found 258.13 [M+H]+. 
Model 2.9.  A solution of BDMC (868 mg, 3.37 mmol) in THF (8 mL) was added to 
a solution of R-3-aminopyrrolidine (650.0 μL, 7.42 mmol) in THF (5 mL).  After one 
day, the solvent was removed by reduced – pressure evaporation and the residue passed 
through a silica gel column using (10:1) Hx:EtOAc until the first two spots passed 
through.  The solvent was then switched to (8:2:1 %) DCM:MeOH:NH4OH to collect 
the product.  Fractions containing pure product were combined and solvent removed to 
give a yellow oil.  Colorless crystals began to form after allowing the oil to stand in open 
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air.  After some time, the crystals were filtered (965 mg, 93.2 %).  1H NMR (500 MHz, 
DMSO-d6, δ):  3.36 – 3.57 (m, 12H), 3.06 (dd, 1H), 1.94 (m, 1H), 1.59 (m, 1H), 1.08 (t, 
J = 6.9 Hz, 12H).  13C NMR (125 MHz, CDCl3, δ):  164.6, 164.3, 54.1, 51.2, 44.1, 41.0, 
34.5, 13.6; MS (ESI) mass calc’d for C15H29N7 = 307.25; found 308.24 [M+H]+. 
Model 2.10.  A solution of model 2.9 (707 mg, 2.30 mmol) and Hunig’s base (0.500 
mL, 2.87 mmol) in THF (2 mL) was added to a solution of cyanuric chloride (128.6 mg, 
0.6973 mmol) in THF (1 mL) at room temperature.  The reaction was subsequently 
heated to 50 oC where it was allowed to react for several days.  The solvent was removed 
by reduced – pressure evaporation and the residue passed through a silica gel column 
using (5:1) Hx:EtOAc.  Fractions containing pure product were combined and had their 
solvent removed to give a colorless foam (479.6 mg, 94.7 %).  1H NMR (500 MHz, 
DMSO-d6, δ):  8.14 (d, NH), 8.04 (d, NH), 8.00 (d, NH), 7.72 (br m, NH), 4.39 (m, 2H), 
3.80 (m, 1H), 3.70 (m, 1H), 3.60 (br m, 2H), 3.48 (m, 16H), 3.43 (m, 2H), 3.37 (m, 2H), 
2.16 (m, 2H), 1.92 (m, 2H), 1.08 (t, 24H).  13C NMR (125 MHz, CDCl3, δ):  168.9, 
165.5, 164.5, 164.3, 51.6, 51.3, 50.8, 50.6, 43.7, 41.0, 31.8, 31.5, 13.5; MS (ESI) mass 
calc’d for C33H56ClN17 = 725.46; found 726.53 [M+H]+. 
Model 2.11.  A solution of model 2.10 (154.8 mg, 0.2131 mmol) in THF (1 mL) was 
added to a solution of pyrrolidine (100 μL, 1.2 mmol) in THF (1 mL) at room 
temperature.  After allowing to react overnight, the solvent was removed by reduced – 
pressure evaporation and the residue passed through a silica gel column using (9:1) 
DCM:MeOH.  Fractions containing pure product were combined and had their solvent 
removed to give a colorless foam (160.1 mg, 98.7 %).  1H NMR (500 MHz, DMSO-
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d6, δ):  6.92 (NH), 6.78 (NH), 6.67 (NH), 4.39 (m, 2H), 3.87 (m, 1H), 3.78 (m, 1H), 3.60 
(m, 2H), 3.47 (m, 16H), 3.38 (m, 6H), 3.25 (m, 2H), 2.10 (m, 2H), 1.91 (m, 2H), 1.82 
(m, 4H), 1.07 (m, 24H).  13C NMR (125 MHz, CDCl3, δ):  164.6, 164.4, 51.8, 50.3, 46.1, 
43.9, 41.0, 31.9, 25.4, 13.6; MS (MALDI) mass calc’d for C37H64N18 = 760.56; found 
761.46 [M+H]+. 
Model 2.12.  A solution of BDMC (814 mg, 3.16 mmol) in THF (8 mL) was added 
to a solution of 4-aminopiperidine (1.00 mL, 9.52 mmol) in THF (5 mL).  After one day, 
the solvent was removed by reduced – pressure evaporation and the residue passed 
through a silica gel column using (19:1) DCM:MeOH until the first spot passed through.  
The solvent system was then switched to (8:2:1 %) DCM:MeOH:NH4OH.  Fractions 
containing pure product were combined and had their solvent removed to give a pale 
yellow solid (739 mg, 72.8 %).  1H NMR (500 MHz, CDCl3, δ):  4.46 (m, 2H), 3.47 (q, J 
= 7.0 Hz, 8H), 2.82 (m, 2H), 2.76 (m, 1H), 1.69 (m, 2H), 1.08 (m, 14H).  13C NMR (125 
MHz, CDCl3, δ):  165.4, 164.9, 49.7, 42.1, 41.1, 35.4, 13.6; MS (ESI) mass calc’d for 
C16H31N7 = 321.26; found 322.28 [M+H]+. 
Model 2.13.  A solution of model 2.12 (700 mg, 2.2 mmol) and Hunig’s base (0.600 
mL, 3.44 mmol) in (1:1) THF:DCM (2 mL) was added to a solution of cyanuric chloride 
(132.5 mg, 0.7186 mmol) in (1:1) THF:DCM (1 mL) at room temperature.  The reaction 
was subsequently heated to 50 oC where it was allowed to react for several days.  The 
solvent was removed by reduced – pressure evaporation and the residue passed through a 
silica gel column using (10:1) Hx:EtOAc.  Fractions containing pure product were 
combined and had their solvent removed to give a colorless foam (526 mg, 97.1 %).  1H 
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NMR (500 MHz, DMSO-d6, δ):  7.87 (d, NH), 7.78 (d, NH), 7.71 (d, NH), 7.38 (d, NH), 
4.55 (m, 4H), 3.92 (m, 2H), 3.47 (m, 16H), 2.86 (m, 4H), 1.79 (m, 4H), 1.36 (m, 4H), 
1.08 (m, 24H).  13C NMR (125 MHz, CDCl3, δ):  169.6, 168.8, 165.4, 165.2, 164.9, 49.1, 
48.6, 42.0, 41.9, 41.7, 41.2, 32.2, 31.9, 31.8, 13.6; MS (ESI) mass calc’d for 
C35H60ClN17 = 753.49; found 754.59 [M+H]+. 
Model 2.14.  A solution of model 2.13 (155.7 mg, 0.2063 mmol) in THF (1 mL) was 
added to a solution of piperidine  (110 μL, 1.1 mmol) in THF (1 mL) at room 
temperature.  After allowing to react overnight, the solvent was removed by reduced – 
pressure evaporation and the residue passed through a silica gel column using (9:1) 
DCM:MeOH.  Fractions containing pure product were combined and had their solvent 
removed to give a colorless foam (153.3 mg, 92.5 %).  1H NMR (500 MHz, DMSO-
d6, δ):  .  13C NMR (125 MHz, CDCl3, δ):  165.5, 164.9, 48.2, 44.2, 42.1, 41.1, 32.4, 
26.0, 25.1, 13.6; MS (ESI) mass calc’d for C40H70N18 = 802.6; found 803.51 [M+H]+. 
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CHAPTER III 
USING NMR SPECTROSCOPY TO PROBE THE CHOREOGRAPHY OF A 
DENDRIMER DANCE* 
 
Introduction 
Since the first reported synthesis of dendrimers,3,4 there have been many efforts to 
determine the conformation of the macromolecules in solution using both experiment 
and theory.1,6-41,79,80  One of the most straightforward questions to ask is, “Where are the 
groups on the periphery (the so-called surface or end groups)?”  Using a self consistent-
field model, de Gennes and Hervet proposed that the dendrimer extends outwardly from 
the core having all of the end groups on or near the periphery of the molecule (i.e., dense 
shell).6  In contrast, Lescanec and Muthukumar’s simplified kinetic model using a 
computer simulation of dendritic growth suggested the maximum density is between the 
assumed dense core and the periphery of the dendrimer as a result of the backfolding of 
the chain ends.8  A more recent self consistent-field model by Boris and Rubinstein 
supports the dense core model: density decreased monotonically from the center of the 
molecule.9  Naylor et al. used computer–assisted molecular modeling to infer that as the 
size increases, the dendrimer’s shape progresses from an open structure to a closed 
spheroid with well–developed cavities and a dense surface.7  Monte Carlo calculations 
performed by Mansfield and Klushin found the chain ends to be distributed throughout  
____________ 
*Reproduced with permission from Moreno, K.X., Simanek, E.E. Macromolecules, 
submitted for publication.  Unpublished work copyright 2007 American Chemical 
Society. 
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the structure and revealed a density maximum midway between the center of mass and 
the periphery.10  Also using Monte Carlo calculations, Welch and Muthukumar reported 
that by varying the ionic strength of the solvent, a reversible transition between a dense 
core and dense shell structure could be achieved.11  Molecular dynamics (MD) 
simulations of dendrimers that incorporate solvent effects have been performed by Murat 
and Grest.12  Their model predicts significant backfolding of the chain ends and a high 
density area located near the core for all independent of the solvent quality.  Their model 
predicts an overall increase in dendrimer density with decreasing solvent quality.  More 
recently, MD simulations performed in explicit solvent have suggested that dendrimer 
can backfold in solution.13,14  In summary, most of the theoretical studies suggest that 
backfolding is a common process of dendrimers. 
Experimental evidence for backfolding has been achieved using various 
techniques.1,15-36,79,80  In poly(amidoamine) (PAMAM) dendrimers, Meltzer et al. 
demonstrated that the chain dynamics did not change dramatically up to the tenth 
generation using NMR spectroscopy.16  They conclude that the branches backfold to 
some extent to relieve steric crowding based on 2H NMR.17  More recently, Chen and 
co-workers demonstrated that upon changing the pH of the solution, a conformational 
change can be induced.22  Unfortunately, the authors could not determine what degree of 
backfolding, if any, was occurring in their system.  In addition to PAMAM dendrimers, 
polyarylether dendrimers have also been examined.  Mourey et al. studied polyaryl ether 
dendrimers using size exclusion chromatography and differential viscometry.24  They 
found that the hydrodynamic radii increased nearly linearly with dendrimer generation 
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and a maximum in the intrinsic viscosity as a function of molecular weight was found.  
More recently, De Backer and co-workers came to similar results using fluorescence 
depolarization measurements.25  Both of these studies are in qualitative agreement with 
the theoretical study of Lescanec and Muthukumar8 in which the end groups can be 
found throughout the dendrimer volume, i.e. backfolding occurs.  Using rotational-echo 
double-resonance (REDOR) NMR, Wooley et al. was able to show that backfolding 
occurs in the solid state.26  Additionally, Gorman and co-workers were able to establish 
that the end groups of polyaryl ether dendrimers come in close proximity to the core.27  
Their studies were performed using a paramagnetic core and measuring the spin-lattice 
relaxation (T1) times of the molecule.  Backfolding was attributed to be the major cause 
of the very rapid electronic energy transfer in polyaryl ether dendrimers.28 
Using viscometry and small-angle neutron-scattering (SANS) measurements of both 
nitrile and amine terminated poly(propylene imine) (PPI) dendrimers, Scherrenberg et al. 
found a linear relationship between the radius of the dendrimer and its generation 
number.29  This linear relationship was independent of the type of end group or solvent 
used.  These results correlate well with the theoretical results of Murat and Grest12 
indicating that PPI dendrimers are flexible with a relatively uniform density distribution 
resulting from some degree of backfolding.  More recently, an extensive SANS study 
demonstrated that the maximum density is located in the center of the molecule and that 
the end groups are backfolded.30  The ‘dendritic box’ synthesized by Jansen et al. takes 
advantage of the end group backfolding to encapsulate guest molecules.31  Crystal data 
later provided direct evidence of the end groups backfolding via hydrogen-bond 
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interactions.33  Chai and co-workers performed an extensive NMR study of PPI 
dendrimers finding evidence for backfolding using 2D NOESY34 and interactions 
between chloroform and dendrimer.35  Their results provide further evidence of the 
flexibility of PPI dendrimers: they observed either a collapsed (backfolded) or extended 
conformation depending on the solvent used. 
The use of NMR to study biomolecules, such as proteins, is a well-established and 
powerful tool.  However, it is difficult to apply these strategies to dendrimers due to the 
degeneracies of signals resulting from the repetitive nature of the macromolecule.  The 
ability to incorporate unique spectral signatures on the end groups greatly facilitates 
inquiry into a fundamental question, backfolding.  Still, size, morphology and dynamics 
of dendrimers have been probed in a limited number of systems.  Studying T1 and spin-
spin relaxation (T2) times of PAMAM dendrimers allowed Meltzer et al. determine that 
there is a gradual increase in segment density and that the terminal groups are not 
densely packed.16,17  By studying the 13C T1 times of a PPI dendrimer with both 
hydrophilic and hydrophobic end groups, Pan and Ford were able to determine that the 
conformation may change by varying the solvent.36  Multi-dimensional NMR techniques 
have been used to characterize dendrimers, determine their conformation and to observe 
host-guest interactions within them.  Chai et al. used 2D and 3D NMR techniques to 
both characterize and determine the conformation of PPI dendrimers.35  To evaluate 
host-guest interactions, Morgan et al., Banerjee et al. and Broeren et al. used 2D NOESY 
to confirm that the guest molecule was interacting with the dendrimer.39-41  To study the 
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secondary interactions of the end groups, VT coefficients and hydrogen/deuterium (H/D) 
exchange studies have been performed.33,37,38   
The goals of these studies are to confirm many of these observations in a single 
dendrimer system and elaborate on more subtle issues of conformation.  In the previous 
chapter, the synthesis of a melamine dendrimer with unique NMR signals from 
periphery to core to aid the investigations of the conformations of triazine dendrimers 
was detailed.  Figure 3.1 reveals the cartoon and chemical structures of the dendrimer 
and a series of models studied in this report. 
Results and Discussion 
The results and discussion are organized around major lessons learned from these 
studies.  In the preceding chapter, the analysis of the 1D NMR led to the conclusion that 
the dendrimer is rich in rotamer populations.  These isomers, resulting from hindered 
rotation about the triazine-N bond, give rise to spectral complexity in the context of 
signal number, degeneracy, and broadness of lines.  Here, three additional lessons 
emerge.  The first lesson learned is that nOe complexity arises with globular structure.  
The implication of this observation as it pertains to backfolding and inter–branch 
communication is described.  The second lesson learned is that solvent is largely 
excluded from the interior of the dendrimer.  The third lesson learned is that each ‘layer’ 
of the dendrimer has different mobility and in a distinct order as evaluated by relaxation 
studies.   
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Figure 3.1.  Cartoon and molecular representation of dendrimer and models. 
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Figure 3.2.  Observed nOes of models and full dendrimer.  Linear model, 3.2, shows 
intra – residue nOes.  Arm model, 3.1, identifies additional nOes not observed in 3.2.  
Dendrimer, 2.8, identifies additional nOes not observed in 3.2 or 3.1. 
 
 
 
Lesson One:  nOe Complexity Emerges with Globular Structure 
Figure 3.2 shows the onset of nOe complexity when comparing the linear model 3.2 
to macromolecule 3.1, representing 1/3 of the dendrimer, to the entire dendrimer 2.8.  
For clarity, only new nOes are shown for 3.1 and 2.8 respectively.  The intra-residue 
nOes are observed in all architectures, but only intraresidue nOes are seen in model 3.2.  
These nOes in the azetidine and piperidine rings suggest that ring interconversion may 
be occurring.  If so, these motions are either conserved in the more complex 
architectures or are supplanted by inter-residue nOes of similar magnitude.  The 
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pyrrolidine ring and peripheral groups separately display nOe between neighboring 
protons.   
Model 3.1 shows evidence for inter–branch communication.  In addition to the 
nOes observed in 3.2, 3.1 has nOes that can only be explained by the two pyrrolidine 
rings interacting with each other (Figure 3.2); specifically, an nOe observed between 
protons HK’—HI and HL’—HI’.  We do not expect an nOe between these resonances 
unless there is inter–branch communication or spin diffusion occurring.  Spin diffusion 
may occur in macromolecular systems when τc >> ωo-1.81  While this affect can lead to 
additional cross–peaks observed between all protons within the same spin system, 
adjusting the mixing time of the NOESY experiment to very short times precludes cross 
relaxation steps from occurring, thus eliminating the cross–peak.  Decreasing the mixing 
time of the NOESY experiment from 300 ms to 50 ms resulted in no noticeable 
differences in the cross–peaks, thus ruling out spin diffusion as a possible cause. 
Dendrimer (2.8) provides evidence for both inter—branch communication and 
backfolding of peripheral groups.  NOESY experiments were performed at various 
temperatures (30–75 oC) and concentrations (0.1–10 %, w/v) in DMSO-d6.  Figure 3.3 
shows a typical NOESY spectrum of 2.8 in the range of 1.0 to 5.0 ppm at 40 oC.  
Multiple cross–peaks are observed in the spectrum both between different spin systems 
and the same spin systems.  Interactions between the peripheral groups and the 
pyrrolidine groups are the only interactions between different spin systems, suggesting 
that the dendrimer end groups are backfolding.  Backfolding of the peripheral groups 
was even observed up to 75 oC.  Upon changing the solvent to CDCl3 or CD3OD, 
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backfolding was no longer observed.  A possible explanation for this result might be that 
DMSO-d6 does not permeate within the dendrimer and only resides outside of the 
dendrimer molecule, while CDCl3 or CD3OD may be able to permeate within the 
dendrimer.  While DMSO-d6 would ordinarily be considered a “good solvent” based on 
similarity in dielectric constants (DMSO = 47.2, MeOH = 33, CHCl3 = 5.5), the most 
readily identifiable difference to us is the inability of DMSO-d6 to donate a hydrogen 
bond.  When the concentration of the dendrimer was increased from 0.001 M to 0.01 M, 
there was little to no change in chemical shift, potentially supporting that DMSO-d6 
resides outside of the dendrimer molecule.  With the solvent molecules residing outside 
of the molecule, this leaves a void within the interior of the dendrimer and the arms are 
most likely to fold back into the dendrimer.  In CDCl3 or CD3OD, the arms are most 
likely in an extended conformation.  Rinaldi came to a similar conclusion with PPI 
dendrimers:35  backfolding occurred in benzene (2.3) but not chloroform (5.5). 
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Figure 3.3.  NOESY spectrum of 2.8 in DMSO–d6 (2 % w/v) at 40 oC.  Black boxes 
identify interactions between different spin systems. 
 
 
 
Lesson Two:  Solvent Is Largely Excluded from the Interior of the Dendrimer 
Both variable temperature NMR and H/D exchange experiments provide a picture of 
the role of solvent. 
Solvent shielding observed in the dendrimer.  Variable temperature NMR studies 
were used to calculate temperature coefficients (Δδ/ΔT) of the dendrimer and the model 
compounds to determine if the NH resonances may be involved in intramolecular 
hydrogen-bonding.  Commonly applied to peptides and proteins, it is generally accepted 
for peptides that if the temperature coefficient is less than -4 ppb/K in aqueous solution, 
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the NH is exposed to solvent and not involved in intramolecular hydrogen-bonding, 
while a temperature coefficient greater than -4 ppb/K is considered to be involved in 
intramolecular hydrogen bonding.82  Although, dendrimers are considered to be similar 
in size to proteins, using similar temperature coefficient constraints to evaluate hydrogen 
bonding of a non-amide NH resonance of our dendrimer in organic solvents may not be 
accurate.  The use of model compounds should be able to give insight into how exposed 
an NH resonance of the dendrimer is to solvent, assuming the NH resonance of the 
model compound is completely exposed to solvent.  These experiments are inherently 
challenging in that multiple NH lines are observed and the addition of a hydrogen bond 
donating solvent like MeOD affects the structure of this dendrimer.   
Table 1 shows the tabulated temperature coefficients of the various NH resonances 
of the dendrimer and model compounds, 2.6, 2.11, 2.14 and 3.1-3.3.  Most useful for us 
is the comparison of the NH resonances of the dendrimer, 2.8, with the respective model 
(2.6, 2.11, 2.14 and 3.3).  Differences between these values are evident, and support a 
conformation wherein the azetidine, pyrrolidine and carbamate NH’s become less 
exposed to solvent.  Under the current architecture of the dendrimer, the piperidine NH 
can not be observed. 
Coefficients for the arm (3.1) and linear (3.2) models when compared with model 
compounds 2.6, 2.11, 2.14 and 3.3 echo similar trends, but direct comparisons between 
these two architectures and the dendrimer are less instructive.  For 3.1, the NH 
resonances for the carbamate and pyrrolidine seem to be less exposed to solvent than 
2.8, while the azetidine NH is even more shielded from solvent.  As with the dendrimer, 
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the piperidine NH could not be observed. For 3.2, we expected the NH resonances to 
have similar coefficients as 2.6, 2.11, 2.14 and 3.3, but for the carbamate and pyrrolidine 
NHs the coefficients have similar values as the dendrimer.  The primary anomaly for 
both models is with the azetidine NH resonance, it is more shielded from the solvent 
than even the azetidines groups of 2.8.  This effect may be due to the fact that the p-
toluidine groups are somehow prohibiting the NH from interacting with the solvent (no 
nOes were observed between the azetidine and p-toluidine groups were observed).   
 
 
Table 1.  VT Coefficients (Δδ/ΔT) of Dendrimer and Model Compound NHsa
 NH Boc Pyr Pipb Az 
 Conformer Anti Anti Syn (E,E) (E,Z) (E,E) (E,Z) (Z,Z)   
 
2.8 -6.88 -5.54 -3.54 -7.61 -5.48    -6.16 -5.25 
 
3.1 -6.86 -4.27 -3.91 -7.69     -4.46  
 3.2 -7.36 -5.39 -4.90 -6.63  -8.31   -4.41  
 2.6         -6.50 -5.24 
 2.14      -8.24 -7.71 -5.10   
 2.11    -8.47 -5.68      
 3.3 -6.23  -4.32        
a  All spectra acquired in DMSO-d6. 
b  Coefficient could not be determined for 2.8 and 3.1. 
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H/D exchange occurs rapidly for azetidine and pyrrolidine NHs.  Hydrogen–
deuterium exchange studies complement the variable temperature studies for identifying 
whether the NH protons are involved in hydrogen-bonding.  Hydrogen-bonded NH 
protons exchange with protic solvents at a much slower rate than NH protons exposed to 
solvent.83  Preliminary studies with the dendrimer using 1H NMR suggested that the NH 
protons of the pyrrolidine and azetidine rings exchange within two minutes, while 
carbamate NH’s did not.  Since the piperidine NH protons are buried under the 
carbamate resonances, no conclusion can be made.  Direct comparison between different 
types of exchangeable protons led us to examine the rate of exchange with model 
compounds 2.6, 2.11, 2.14 and 3.3.  For 2.6, 2.11, 2.14 and 3.3, we observe exchange of 
the NH protons for 2.11 & 2.14 within two minutes but not for 2.6 or 3.3.  The 
carbamate protons of 3.3 showed a gradual decrease in signal intensity over a twelve 
hour period.  The NHs of 2.6 decreased more rapidly; equilibrium occurred in about 2-3 
hours.  The ‘slow’ exchange of 1H for 2H of the carbamate NHs of the dendrimer, as 
compared to 2.14 and 2.11, led us to conclude that these protons are involved in 
hydrogen–bonding.  A comparison between the VT coefficients and these exchange 
studies could not be made under the conditions employed.  This is due to methanol 
affecting the dendrimer conformation in solution as evidenced from a 2D NOESY 
experiment using 5% CD3OD in DMSO-d6. 
Lesson Three: Each ‘Layer’ of the Dendrimer Has Different Mobility   
The mobility of each ‘layer’ is different as judged from spin–lattice relaxation (T1) 
and spin–spin relaxation (T2) studies.  Figure 3.4 displays the results of the proton 
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relaxation of our dendrimer.  The relaxation times depicted here are average values for 
each linker of the molecule.  Evident in both sets of data, we find that each linker 
exhibits a different relaxation time when compared to the other segments of the 
dendrimer.  The data also show a specific order:  for T1 relaxation, the peripheral groups 
have the shortest time and the time increasing towards the core of the molecule.  For T2 
relaxation, the opposite is true.  The peripheral groups have the longest relaxation time, 
and these times decrease as one moves towards the core of the molecule.  This suggests 
that our dendrimer tumbles slowly or in the ‘slow’ regime of the T1/T2 vs τc curve.  The 
conceptual picture that emerges has the peripheral groups are moving more than 
pyrrolidine segment which moves more than the piperidine and so on.  The data also 
show that while an increase in temperature also increases the movements of the 
molecule, the changes are greatest near the outer portions of the molecule.  In this study, 
the relaxation is attributed to dipole–dipole relaxation between two nuclei.  Meltzer and 
Gorman previously concluded that other mechanisms for nuclear relaxation are generally 
insignificant in solution and where chemically identical but topologically different nuclei 
are considered.16,27
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Figure 3.4. T1/T2 vs temperature plot of the various linkers within 2.8.  Solid lines refer 
to T1 relaxation time and the dashed lines refer to T2 relaxation time. 
 
 
 
Conclusions 
The result of these studies is a conceptual image of the conformational musings of a 
third generation dendrimer based on triazines in DMSO.  Evidence from a variety of 
other, often disparate studies, suggests that this picture may be more general.  These 
results are in agreement with previously published reports by other groups, such as 
Lescanec8, Meltzer16,17, Wooley26, Gorman27, Meijer31,33, and Rinaldi.35  These reports 
provide evidence for backfolding in different dendrimer systems using different 
techniques and different dendrimer architectures.  Lescanec used computer simulation of 
dendritic growth to show the chain ends backfold.  Meltzer used 2H NMR and relaxation 
studies to provide evidence for backfolding in PAMAM dendrimers.  Both Wooley and 
Gorman studied polyaryl ether dendrimers and demonstrated that backfolding occurs 
using REDOR NMR and relaxation studies, respectively.  By using 2D NMR, both 
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Meijer and Rinaldi showed that PPI dendrimers can backfold.  Meijer was able to 
provide crystallographic evidence with a G1 PPI dendrimer.  As with our case, Rinaldi 
was able to show that the backfolding is a function of solvent.  Relaxation studies of 
PAMAM, PPI and polyaryl ether dendrimers show that the exterior of the dendrimer has 
more mobility and the interior of the dendrimer.16,17,27,31,35  This system not only agrees 
with these studies but also provides evidence that each layer of the dendrimer has 
different mobilities.  
Most useful to us is to draw an analogy.  In consideration of any number of classical 
dances―the waltz, tango, foxtrot, or chicken―we are disposed to pick the Macarena as 
most representative of the motions of triazine dendrimers in DMSO-d6.  The preliminary 
studies described in the preceding chapter suggest a richness in rotational isomers (hands 
up/hands down and bending joints).  These studies complement this picture with 
evidence of backfolding of peripheral groups (hands to head/shoulders/hips).  Similarly, 
in accordance with relaxation studies, these peripheral groups move more rapidly than 
groups closer to the interior.  Finally, relaxation appears to be manifested primarily by 
these movements and less so by tumbling events (jump).  The lack of concentration 
dependence on these events suggests that the molecule dances alone and not in concert 
with other partners.  Finally, when the solvent/music changes, a different dance results. 
Experimental Section 
Materials.  Chemicals were purchased from Aldrich and Acros and used without 
further purification.  All solvents were ACS grade and used without further purification.  
All mass spectral analyses were carried out by the Laboratory for Biological Mass 
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Spectrometry at Texas A&M.  Synthetic descriptions for 2.5, 2.6, 2.8, 2.11, 2.14, and 3.3 
can be found in chapter II.  Selected spectra of the compounds can be found in Appendix 
B. 
Preparation of NMR samples.  All compounds were pumped before use.  
Deuterated solvents were purchased from Acros, used without further purification, and 
kept under moisture free conditions.  DMSO-d6 was purchased in 1.0 mL N2 flushed 
ampules.  Preparation of the DMSO-d6 samples was performed in a glovebox under 
nitrogen.  Dendrimer samples were prepared in concentrations of 0.001 M (12 mg/mL) 
solutions.  The remaining compounds were prepared in 30 mg/mL solutions in the 
appropriate solvent. 
NMR measurements.  (a) 1D NMR experiments.  NMR spectra were recorded on 
a Varian Inova 500 MHz spectrometer in CDCl3, CD3OD or DMSO–d6.  Unless 
otherwise noted, all 1D 1H and 13C spectra were recorded at 25.0 + 0.1 oC and 2D 
spectra at 35.0 + 0.1 oC.  In CDCl3, 1H spectra were referenced to to 7.26 ppm and 13C to 
77.16 ppm.  In CD3OD, 1H spectra were referenced to 3.31 ppm.  In DMSO–d6, 1H 
spectra were referenced to 2.50 ppm and 13C spectra to 39.52 ppm.  The 1H spectra of 
the dendrimer were acquired at 500 MHz by using a 3.5 s acquisition time, 4.5 kHz 
spectral window, and a 7.3 μs pulse width.  The 1H spectra of the model compounds 
were acquired at 500 MHz by using a 3.5 s acquisition time, 5.25 kHz spectral window, 
and a 2.3 μs pulse width.  All 13C spectra were acquired at 125 MHz by using a 2.0 s 
acquisition time, 22.6 kHz spectral window, 1.0 s relaxation delay and a 5.6 μs pulse 
width with WALTZ-16 modulated 1H decoupling. 
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(b) 2D NMR experiments.  Various NOESY experiments were carried out for the 
dendrimer and two different ones for 2 and 3.  All NOESY experiments for the 
dendrimer were carried out with a 4.5 kHz spectral window in f1 and f2, 0.227 s 
acquisition time, 7.3 μs (90o) pulse width, 10.0 s relaxation delay, and 16 transients were 
averaged for each of the 2 x 256 increments.  One set of experiments varied the 
temperature from 35 to 75 oC with a mixing time of 0.300 s.  A final experiment used a 
mixing time of 0.050 s and a temperature of 35 oC.  NOESY experiments for the model 
compounds, 3.1 and 3.2, differed from the dendrimer parameters by using a 5.25 kHz 
spectral window in f1 and f2 and using a temperature of 35 oC for all experiments.  Two 
experiments were performed for each compound, one with a mixing time of 0.300 s and 
another with a mixing time of 0.050 s.  All spectra were zero–filled to a 1024 x 1024 
data matrix before Fourier transformation. 
Relaxation studies.  Spin–lattice (T1) relaxation was determined using a typical 
inversion recovery experiment (180—τ—90).  Spin–spin (T2) relaxation was determined 
using a Carr-Purcell-Meiboom-Gill spin–echo experiment.84-86  For each experiment, 
variable delays (τ) were selected to span a range sufficient to probe relaxation up to five 
times the values of all of the protons under consideration.  A minimum of 7 τ values 
were employed.  Data were fit using Varian’s integrated software.  Samples were 
prepared as described above. 
Proton-deuterium exchange experiment.  Samples were prepared by making a 10 
mg/mL solution using dry DMSO-d6 (0.750 mL) and CD3OD (0.050 mL) in a dry NMR 
tube.  A series of 1H NMR spectra were taken at increasing intervals over a period of 6 
 61
hrs (minimum interval = 1 min, maximum interval = 30 min).  Parameters used were 
those stated above for 1H spectra of dendrimer. 
Variable–temperature NMR experiments.  A dendrimer sample was prepared as 
stated in the sample preparation section.  A dry screw-cap NMR tube was used.  The 
VT-NMR experiment was performed using a Varian Inova 500 MHz spectrometer.  The 
spectra were recorded at 298, 308, 318, 328, 338, 348 K, as set by a temperature 
programmer.  The temperature coefficient (Δδ/ΔT) was obtained by measuring the slope 
of a graph of chemical shift (δ) versus temperature (K). 
2,4-Bis(p-toluidine)–6-(1-Boc-3-amino-azetidine)-1,3,5–triazine.  Bis(p-
toluidine)–monochloro–triazine (721.8 mg, 2.22 mmol) and BEMP resin (2.32 g, ~ 5.1 
mmol) was added to a solution of 1-boc-3-amino-azetidine (400.4 mg, 2.32 mmol) in 
THF (7 mL) at room temperature.  The reaction was heated to 70 oC and left to react for 
several days.  The BEMP resin was filtered out and solvent removed by reduced pressure 
evaporation.  The residue was passed through a silica gel column using (50:1) 
DCM:MeOH.  Fractions containing pure product were combined and solvent removed to 
give a colorless foam (1.00 g, 98.1 %).  1H NMR (500 MHz, CDCl3, δ):  7.40 (d, J = 8.4 
Hz, 4H), 7.11 (d, J = 8.4 Hz, 4H), 5.52 (br s, NH), 4.63 (m, 1H), 4.22 (t, J = 8.46 Hz, 
2H), 3.72 (dd, 2H), 2.32 (s, 6H), 1.82 (br s, NH), 1.45 (s, 9H).  13C NMR (125 MHz, 
CDCl3, δ):  165.64, 164.48, 156.25, 136.11, 129.43, 121.20, 120.65, 79.80, 56.83, 40.81, 
28.52, 20.94; MS (ESI) mass calc’d for C25H31N7O2 = 461.25; found 462.25 [M+H]+. 
Arm model (3.1).  2,4-Bis(p-toluidine)–6-(1-Boc-3-amino-azetidine)-1,3,5–triazine 
(61.0 mg, 0.1322 mmol) was treated with a (1:1) mixture of DCM/TFA (4 mL) 
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overnight at room temperature.  The solvent was removed by reduced pressure 
evaporation.  The residue was redissolved in a MeOH/TEA solution and then removed 
my reduced pressure evaporation.  This was accomplished 3 times or until acid was 
neutralized.  The residue was dissolved in THF (2 mL) followed by the addition of 
BEMP resin (500 mg, ~ 1.1 mmol) and solid 1.5 (1504.8 mg, 0.4004 mmol).  The slurry 
was then heated to 70 oC and left to react for several days.  The solution was then 
allowed to cool and filtered to remove the BEMP resin.  The solvent was removed by 
reduced – pressure evaporation and the residue passed through a silica gel column using 
(50:1) DCM:MeOH.  Fractions containing pure product were combined to give a 
colorless foam (327.96 mg, 60.8 %).  1H NMR (500 MHz, DMSO-d6, δ):  8.99 (br s, 
NH), 8.87 (br s, NH), 7.63 (m, 4H), 7.58 (br s, NH), 7.05 (m, 4H), 6.90 (br s, NH), 6.79 
(br s, NH), 6.72 (br s, NH), 6.66 (br s, NH), 6.63 (br s, NH), 6.37 (br s, NH), 4.68 (m, 
1H), 4.56 (m, 4H), 4.47 (m, 4H), 4.40 (m, 2H), 4.19 (m, 2H), 3.94 (m, 2H), 3.87 (m , 
2H), 3.77 (m, 4H), 3.63 (m, 4H), 3.40 (m, 36H), 3.26 (m, 4H), 2.91 (m, 36H), 2.24 (s, 
6H), 2.11 (m, 4H), 1.89 (m, 4H), 1.77 (m, 4H), 1.63 (m, 32H), 1.41–1.25 (m, 148H).  
13C NMR (125 MHz, DMSO-d6, δ):  166.47, 165.48, 165.09, 164.79, 164.19, 163.90, 
163.11, 155.49, 155.36, 137.55, 130.39, 128.61, 120.11, 119.93, 77.38, 56.37, 50.64, 
49.53, 49.07, 47.78, 47.38, 46.77, 43.97, 43.74, 43.55, 41.54, 41.06, 37.94, 37.63, 37.46, 
31.63, 30.66, 28.21, 20.35.  MS (MALDI) mass calc’d for C195H330N64O32 = 4080.62; 
found 4081.96 [M+H]+. 
Mono(p-toluidine)-dichlorotriazine (pTolCl2).  A solution of p-toluidine (4.39 g, 
41 mmol)  and Hunig’s base (DIPEA, 15.0 mL, 86 mmol) in THF (100 mL) was added 
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dropwise to an ice-cold solution of cyanuric chloride (7.56 g, 41 mmol) in THF (100 
mL).  The reaction was allowed to stir for 2 hours at 0 oC.  The solvent was removed by 
reduced–pressure evaporation and the residue passed through a silica gel column using 
(50:1) CHCl3:MeOH.  Fractions containing pure product were combined and solvent 
removed to give an orange solid (8.3 g, 79.5 %).  1H NMR (500 MHz, CDCl3, δ):  7.64 
(brs, 1H), 7.39 (d, J = 8.48 Hz , 2H), 7.20 (d, J = 8.45 Hz , 2H), 2.36 (s, 3H).  13C NMR 
(125 MHz, CDCl3, δ):  171.43, 170.21, 164.23, 136.02, 133.11, 129.93, 121.69, 21.10.  
MS (ESI) mass calc’d for C10H8Cl2N4 = 254.01; found 255.02 [M+H]+. 
Mono(p-toluidine)-mono(Bis(3-Boc-3-aminopropyl)amine)-monochlorotriazine 
(pTol-BBT-Cl).  Hunig’s base (DIPEA, 12.0 mL, 69 mmol) was added to a slurry of 
pTolCl2 (8.0 g, 31.4 mmol) in THF:DCM (1:1, 150 mL), which allowed the starting 
material to dissolve.  Solid bis(3-BOC-3-aminopropyl)amine (10.42g, 31.4 mmol) was 
then added to the solution at room temperature.  The reaction was allowed to stir for 
overnight at room temperature.  The solvent was removed by reduced–pressure 
evaporation and the residue passed through a silica gel column using (50:1) 
CHCl3:MeOH.  Fractions containing pure product were combined and solvent removed 
to give an orange solid (12.73 g, 73.8 %).  1H NMR (500 MHz, DMSO-d6, δ):  9.98 (br 
s, NH), 7.58 (m, 2H), 7.13 (d, 2H), 6.84 (br m, NH), 6.79 (br m, NH), 6.47 (br m, NH), 
3.50 (m, 4H), 2.99 (m, 2H), 2.94 (m, 2H), 2.25 (s, 3H), 1.73 (m, 2H), 1.67 (m, 2H), 1.37 
(m, 18H).  13C NMR (125 MHz, DMSO-d6, δ):  167.88, 164.21, 162.94, 155.58, 155.48, 
136.28, 131.68, 128.96, 119.76, 77.50, 77.45, 45.34, 44.62, 37.88, 37.50, 28.22, 28.20, 
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27.78, 27.44, 20.38.  MS (ESI) mass calc’d for C26H40ClN7O4 = 549.28; found 550.31 
[M+H]+. 
Mono(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidino-
triazine (pTol-BBT-Pyr).  A solution of pTol-BBT-Cl (7.0 g, 12.8 mmol) in THF (55 
mL) was added dropwise to a solution of R-3-amino-pyrrolidine (2.5 mL, 28.6 mmol) in 
THF (5 mL) at room temperature.  After 1 day, the solvent was removed by reduce–
pressure evaporation and the residue passed through a silica gel column using (9:1) 
CHCl3:MeOH.  Fractions containing pure product were combined and solvent removed 
to give an orange foam (7.48 g, 97.4 %).  1H NMR (500 MHz, DMSO-d6, δ):  8.78 (m, 
NH), 7.65 (d, 2H), 7.04 (d, 2H), 6.79 (br s, NH), 6.70 (br s, NH), 6.51 (br s, NH), 6.41 
(br s, NH), 3.60 (m, 2H), 3.49 (m, 6H), 3.30 (m, 1H), 3.15 (m, 1H), 2.95 (m, 4H), 2.22 
(s, 3H), 1.97 (m, 1H), 1.68 (m, 5H), 1.37 (s, 18H).  13C NMR (125 MHz, DMSO-d6, δ):  
164.29, 163.53, 163.16, 155.54, 155.43, 138.24, 129.54, 128.61, 119.11, 77.41, 54.21, 
54.06, 50.54, 50.39, 44.19, 44.08, 43.97, 43.73, 37.97, 37.76, 37.61, 33.92, 33.82, 28.22, 
28.11, 20.30.  MS (ESI) mass calc’d forC30H49N9O4 = 599.39; found 600.41 [M+H]+. 
Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-
mono-chlorotriazine (pTol2-BBT-Pyr-Cl).  A solution of Hunig’s base (DIPEA, 4.1 
mL, 23.5 mmol) and pTol-BBT-Pyr (6.93 g, 11.56 mmol) in THF (25 mL) was added to 
a solution pTolCl2 (2.95 g, 11.56 mmol) in THF (25 mL) at room temperature.  After 
allowing to react overnight, the solvent was removed by reduced–pressure evaporation 
and the residue passed through a silica gel column using (50:1) CHCl3:MeOH.  Fraction 
containing pure product were combined and solvent removed to give a foam (9.11 g, 
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96.3 %).  1H NMR (500 MHz, DMSO-d6, δ):  10.08 (br s, NH), 10.03 (br s, NH), 9.89 
(br s, NH), 8.85 (br s, NH), 8.80 (br s, NH), 8.50 (br s, NH), 8.46 (br s, NH), 8.35 (br s, 
NH), 7.70-7.56 (br m, 4H), 7.15-7.02 (br m, 4H), 6.80 (br s, NH), 6.72 (br s, NH), 6.62 
(br s, NH), 4.55 (20 %) & 4.45 (80 %) (m, 1H), 3.89-3.75 (br m, 1H), 3.74-3.65 (br m, 
1H), 3.64-3.55 (br m, 2H), 3.49 (m, 4H), 2.97 (m, 4H), 2.24 (s, 3H), 2.23(s, 3H), 2.18 
(m, 1H), 2.01 (m, 1H), 1.69 (m, 4H), 1.37 (s, 15H), 1.33 (s, 3H).  13C NMR (125 MHz, 
DMSO-d6, δ):  168.18, 167.72, 165.20, 164.28, 163.45, 163.22, 155.55, 155.44, 138.10, 
136.31, 136.16, 131.85, 129.66, 128.98, 128.87, 128.64, 128.58, 120.14, 119.85, 119.19, 
119.13, 77.41, 51.10, 50.65, 50.15, 49.75, 43.99, 43.87, 37.98, 37.70, 30.26, 29.80, 
28.22, 20.40, 20.35, 20.31, 20.24.  MS (MALDI) mass calc’d forC40H56ClN13O4 = 
817.43; found 818.13 [M+H]+. 
Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-
mono-piperidinotriazine (pTol2-BBT-Pyr-Pip).  A solution of pTol2-BBT-Pyr-Cl 
(8.52 g, 10.42 mmol) in THF (45 mL) was added dropwise to a solution of 4-
aminopiperidine (3.50 mL, 33.34 mmol) in THF (5 mL) at room temperature.  After 
allowing to stir overnight the solvent was removed by reduced–pressure evaporation and 
the residue passed through a silica gel column using (19:1) CHCl3:MeOH.  After all 
impurities were purified away, the solvent system was switched to (9:1) CHCl3:MeOH 
to collect the product.  Fractions containing pure product were combined and solvent 
removed to give a colorless foam (8.1 g, 88.1 %).  1H NMR (500 MHz, DMSO-d6, δ):  
8.94 (br s, NH), 8.91 (br s, NH), 8.84 (br s, NH), 8.81 (br s, NH), 8.72 (br s, NH), 7.69–
7.58 (br m, 4H), 7.15 (br s, NH), 7.12, (br s, NH), 7.04 (m, 4H), 6.96 (br s, NH), 6.80 (br 
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s, NH), 6.72 (br s, NH), 6.65 (br s, NH), 6.51 (br s, NH), 6.42 (br s, NH), 4.57–4.42 (br 
m, 3H), 3.81 (m, 1H), 3.70 (m, 1H), 3.53 (br m, 2H), 3.50–3.39 (br m, 4H), 3.01 – 2.86 
(br m , 6H), 2.81 (m, 1H), 2.22 (s, 5H), 2.17 (m, 2H), 1.99 (m, 1H), 1.77–1.62 (br m, 
6H), 1.37 (75 %) & 1.34 (25 %) (m, 18H), 1.13 (m, 2H).  13C NMR (125 MHz, DMSO-
d6, δ):  165.56, 165.44, 164.30, 164.23, 164.02, 163.51, 163.23, 155.54, 155.41, 138.19, 
138.15, 138.01, 129.88, 129.60, 128.61, 119.50, 119.30, 119.14, 77.40, 51.65, 51.21, 
51.04, 49.84, 49.60, 48.41, 44.12, 44.00, 43.76, 41.42, 37.97, 37.70, 34.83, 30.71, 30.48, 
30.17, 28.22, 20.20.  MS (ESI) mass calc’d for C45H67N15O4 = 881.55; found 882.22 
[M+H]+. 
Tris(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-
monopiperidine-monochlorotriazine (pTol3-BBT-Pyr-Pip-Cl).  A solution of pTol2-
BBT-Pyr-Pip (5.35 g, 6.06 mmol) in THF (20 mL) was added to a solution of pTolCl2 
(1.54 g, 6.05 mmol) and Hunig’s base (2.2 mL, 12.6 mmol) in THF (5 mL) at room 
temperature.  The solution was heated for 8 hr and then solvent was removed by reduced 
– pressure evaporation.  The residue was passed through a silica gel column using (50:1) 
CHCl3:MeOH.  Fractions containing product were combined and solvent removed to 
give a yellow foam (6558.26 mg, 98.5 %).  1H NMR (500 MHz, DMSO-d6, δ):  10.01 
(br s, NH), 9.84 (br s, NH), 9.00 (br s, NH), 8.97 (br s, NH), 8.84 (br s, NH), 8.81 (br s, 
NH), 8.78 (br s, NH), 8.22 (br s, NH), 7.99 (br s, NH), 7.71–7.58 (br m, 6H), 7.23 (br s, 
NH), 7.19 (br s, NH), 7.12 (d, 2H), 7.09–7.00 (br m, 4H), 6.97 (br s, NH), 6.80 (br s, 
NH), 6.72 (br s, NH), 6.65 (br s, NH), 6.51 (br s, NH), 6.42 (br s, NH), 4.71–4.58 (br m, 
2H), 4.56–4.45 (br m, 1H), 4.10–3.95 (br m, 1H), 3.84 (m, 1H), 3.80–3.67 (br m, 1H), 
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3.55 (m, 2H), 3.48 (m, 4H), 2.98 (m, 6H), 2.25 (s, 3H), 2.22 (s, 6H), 2.19 (m, 1H), 2.00 
(m, 1H), 1.96–1.82 (br m, 2H), 1.70 (m, 4H), 1.44 (m, 2H), 1.37 (80 %) & 1.34 (20 %) 
(m, 18H).  13C NMR (125 MHz, DMSO-d6, δ):  168.39, 167.76, 165.61, 165.48, 164.70, 
164.34, 164.29, 164.08, 163.53, 163.27, 155.55, 155.43, 138.19, 137.96, 136.32, 131.85, 
129.99, 129.09, 128.90, 128.87, 128.72, 128.63, 120.28, 119.92, 119.58, 119.36, 119.16, 
77.41, 51.72, 51.12, 49.91, 49.63, 48.72, 47.87, 44.14, 44.01, 43.78, 41.60, 38.00, 37.70, 
31.22, 30.82, 30.20, 28.22, 20.40, 20.35, 20.31.  MS (ESI) mass calc’d for 
C55H74ClN19O4 = 1099.59; found 1100.10 [M+H]+. 
Linear model (3.2).  2,4-Bis(p-toluidine)–6-(1-Boc-3-amino-azetidine)-1,3,5–
triazine (450 mg, 0.977 mmol) was deprotected using a solution of (1:1) TFA:DCM (2 
mL).  After a couple of hours, the solvent was removed by reduced–pressure evaporation 
to give a yellow oil.  The oil was dissolved in MeOH and the solvent removed again.  
This procedure of dissolving in MeOH was performed multiple times until the scent of 
TFA was no longer detected.  The residue was dissolved in THF (10 mL) followed by 
the addition of BEMP resin (1.72 g, ~ 3.78 mmol) and pTol3-BBT-Pyr-Pip-Cl (3.23 g, 
2.93 mmol).  The reaction was then heated to 70 oC and allowed to stir for several days.  
Upon completion of the reaction, the BEMP resin was filtered and washed.  The filtrate 
was subsequently concentrated and passed through a silica gel column using (50:1) 
CHCl3:MeOH: .  Fractions containing product were combined and solvent removed to 
give a colorless foam (198.7 mg, 14.3 %).  1H NMR (500 MHz, DMSO-d6, δ):  9.04 (br 
s, NH), 9.03 (br s, NH), 8.98 (br s, NH), 8.95 (br s, NH), 8.89 (br s, NH), 8.84 (br s, 
NH), 8.81 (br s, NH), 8.76 (br s, NH), 7.70–7.60 (br m, 10H), 7.24–7.13 (br m, NH), 
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7.10–7.00 (br m, 10H), 6.96 (br s, NH), 6.80 (br s, NH), 6.72 (br s, NH), 6.66 (br s, NH), 
6.50 (br s, NH), 6.42 (br s, NH), .4.75 (m, 1H), 4.71–4.57 (br m, 2H), 4.56–4.45 (br m, 
1H), 4.35–4.21 (br m, 2H), 4.09–4.02 (br m, 1H), 4.02–3.91 (br m, 2H), 3.83 (m, 1H), 
3.79–3.65 (br m, 1H), 3.54 (m, 2H), 3.48 (m, 4H), 2.96 (m, 6H), 2.25 (s, 6H), 2.22 (s, 
9H), 2.18 (m, 1H), 1,99 (m, 1H), 1.95–1.84 (br m, 2H), 1.69 (m, 4H), 1.44 (m, 2H), 1.37 
(80 %) & 1.33 (20 %) (m, 18H).  13C NMR (125 MHz, DMSO-d6, δ):  166.15, 165.59, 
165.45, 165.09, 164.81, 164.30, 164.20, 164.03, 163.90, 163.81, 163.51, 163.23, 155.54, 
155.41, 138.15, 138.06, 137.97, 137.55, 130.45, 129.88, 129.60, 128.64, 120.13, 119.96, 
119.49, 119.28, 119.15, 77.40, 56.52, 51.67, 51.01, 49.85, 49.56, 47.78, 47.38, 44.12, 
44.00, 43.77, 41.81, 41.11, 41.00, 37.98, 37.68, 31.51, 30.73, 30.15, 28.22, 20.36, 20.29.  
MS (ESI) mass calc’d for C75H96N26O4 = 1424.81; found 1425.16 [M+H]+. 
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CHAPTER IV 
SYNTHESIS OF AND CHARACTERIZATION OF A PLATINATED TRIAZINE 
DENDRIMER 
 
Introduction 
First synthesized in 1845,87 cis-diamminedichloroplatinum(II)’s (cis-platin) 
antitumor activity was discovered by Rosenberg in 1965 by demonstrating the inhibition 
of cell division in E. coli cells.88,89  Since the first patient received cis-platin as an 
antitumor agent in 1971, cis-platin received worldwide approval for general oncology 
treatment 1978.90  Worldwide, only four platinum complexes are approved for the 
treatment of cancer (Figure 4.1):  cis-platin (worldwide), carboplatin (worldwide), 
nedaplatin (Japan), and oxaliplatin (Europe).91  More recently, other antitumor drugs, 
such as paclitaxel, 5-fluorouracil, methotrexate, bleomycin, and cytarabine, have been 
used in combination with these platinum complexes to fight drug resistance.92-97
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Figure 4.1. Currently approved platinum antitumor drugs around the world. 
 
 
 
Hydrolysis of cis-Platin is dependent on the pH, temperature, time and concentration 
of associated reactants:  chloride and ammonia.94,98-101  Due to the high concentration of 
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chloride in the blood, hydrolysis of cis-platin is minimized (circled in Figure 4.2).  cis-
Platin enters the cell through diffusion.  Low chloride concentration in the cell 
hydrolyzes cis-platin to the monoaqua or diaqua species (boxed in Figure 4.2).  It is 
believed that the active intracellular form is the monoaqua species. 
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Figure 4.2.  Possible hydrolysis products of cis-platin.104
 
 
 
Binding of the monoaqua species with DNA nucleotides appears to correlate with the 
antineoplastic activity of cis-platin.102  Formation of inter/intrastrand cross-links between 
the DNA bases causes perturbations of the secondary structure of DNA, which inhibits 
DNA replication and transcription leading to cell death.93,103  Guanine binding is the 
preferred site of complexation through the N7 atom of the purine ring.  Though guanine 
is preferred binding may also occur with the purine ring of adenine and the N3 of the 
pyrimidine ring in cytosine and uracil.  Figure 4.3 shows the three general cross-links 
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that exist:  interstrand, DNA-protein, and intrastrand.  Some of the cross-links are too 
small to be repaired by damage recognition proteins.104
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Figure 4.3.  Possible cross-links formed by cis-platin. 
 
 
 
As with most chemotherapeutic drugs, toxicity is an issue.  Some side effects include 
gastrointestinal problems such as acute nausea, vomiting, diarrhea; occasional liver 
dysfunction; myelosuppression involving anemia, leukopenia, and thrombocytopenia; 
nephrotoxicity, immunosuppresion, hypomagnesia, hypocalcemia, and 
cardiotoxicity.90,91,104  Kidney damage is believed to be the most serious side effect due 
to the rapid excretion of the platinum within hours of administration, exposing them to 
bursts of high concentrations of platinum.98,105,106   
Polymer-bound platinum(II) conjugates, such as platinum(II)-polyamines (Figure 
4.4), have shown promise in being antitumor agents by displaying lower toxicity towards 
normal cells, thus increasing the dosage.104  The activity of the cis-platin derivative was 
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not affected by the polymer and solution stability of the platinum is increased when 
bound to a polymer as compared to cis-platin in solution.107,108  High polydispersity and 
higher toxicity of some polyamine polymers are problems for the polymers to be used as 
chemotherapeutic drugs.109   
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Figure 4.4.  Polymer-platinum conjugates studied for chemotherapy. 
 
 
 
Though the polydispersity of polymers was an issue, studies did continue to 
investigate the possibility of using polymer-platinum conjugates as chemotherapeutic 
agents.108,110-117  Allcock and coworkers prepared polyphosphazene based platinum 
complexes and found an inhibition of 86% in the Ehrlich ascites tumor regression test 
and a 5/7 survival after the eighth day for the P388 lymphocytic leukemia survival 
mouse test.110,111  Conjugation of polyetheleneimine (PEI) with tetrachloroplatinum (II) 
formed 5-membered rings within the polymer structure (Figure 4.4). 112,113  Though the 
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ring systems were favored, cross-linking was possible.  Insoluble portions in DMSO 
were assumed to be cross-linker polymers.  Tests against L929 cells and HeLa cells, the 
polymers showed equivalent activity as cis-platin but at lower concentrations than cis-
platin.  Platinum was bound to the polysaccharide, chitosan (Figure 4.4), to introduce not 
only water solubility but also biodegradability.  Three binding architectures of 
tetrachloroplatinum (II) with chitosan are possible and lack of complete solubility was 
consistent with some cross-linking between the polymer chains.114,115  Duncan studied 
various copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) and peptidyl 
spacers that contained either carboxylate or amino-end groups for platinum 
attachment.116  Platinum release rates showed that the carboxylated polymers were more 
than 15X faster than the amine polymer.  The cytotoxicity of the carboxylated polymer 
was similar to that of cis-platin in vitro but the amine polymer showed no signs of 
cytotoxicity.  When studied intraperitoneally (IP), neither cis-platin nor the HPMA 
polymers showed signs of activity; but intravenously (IV), cis-platin was still inactive 
but the HPMA polymers showed significant antitumor activity. 
Few studies exist for dendrimer-platinum systems for cancer therapeutics.117-120  
Jansen and co-workers used a generation one PPI dendrimer to complex four cis-platin 
molecules forming a tetra[(tri-amino)monochloroplatinum] complex.117  Jansen was able 
to show that the tetranuclear complex could bind four molecules of 
guanosinemonophosphate (GMP) at their N7 position.  The dendrimer-platinum complex 
showed lowered cytotoxicity compared to cis-platin against L1210 cells and seven 
human cell lines.  Also studying a G1 PPI dendrimer complexed to platinum, Kapp et. al. 
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found that the dendrimer showed higher transport of platinum to the cell (20X) and DNA 
binding (700X) than free cis-platin.118  Interestingly, this dendrimer-platinum complex 
was not as cytotoxic as free cis-platin, though more cytotoxic than other small molecule 
platinum complexes studied.  Duncan et. al. were able to demonstrate that G3.5 
PAMAM dendrimers treated with cis-platin showed similar activity IP as free cis-platin 
against L1210 cells and showed antitumor activity IV against subcutaneous B16F10 
tumors, while free cis-platin was not active.119  The platinum loading of the dendrimers 
was about 23 wt %.  The dendrimer was 8 fold less toxic than free cis-platin and showed 
selective accumulation in the solid tumor tissue by the enhanced permeability and 
retention (EPR) effect. 
This chapter describes the efforts to synthesize a G3 triazine-based dendrimer with 
malonic acid end-groups to bind a dihalogen-diamineplatinum (II) complex, thus 
mimicking carboplatin.  Characterization of the intermediates includes 1H and 195Pt 
NMR, mass analysis and IR.  The use of these techniques helps identify the existence of 
the appropriate intermediates.  The chapter ends with a discussion about future directions 
for this project and efforts to modify the synthesis to more soluble products. 
Synthesis 
The platinated dendrimer was synthesized by modification of an amine-terminated 
generation two triazine dendrimer, 4.2 (Figure 4.5).56,121  The ester peripheral group, 4.1, 
was synthesized by treating 2-amino malonate diethyl ester with cyanuric chloride.  
Treatment of 4.2 with a slight excess of 4.1 gives 4.3.  Triazine dendrimers are 
inherently water insoluble.  To make the dendrimer more water soluble, a reactive group 
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must be installed to attach water solubilizing groups such as polyethylene glycol (PEG).  
4-Aminomethylpiperidine was chosen to provide enough reactivity to react with the 
twelve monochloro groups of the dendrimer and have a free amine for attachment of 
PEG.  Substitution of the chlorides with 4-aminomethylpiperidine gives 4.4.  Attempts 
were made to attach the PEG groups and purify the pegylated dendrimer.  It became 
apparent that with the PEG groups attached, characterization or the synthesis of the final 
product was going to be difficult.  Once the PEG groups were attached, the crowding the 
PEG groups would cause around the malonic acid groups may not allow for the platinum 
to bind.  The proton NMR signal would be saturated with the PEG signal impeding any 
noticeable shifts of the protons α to the carboxylates upon platinum binding.  The 
synthesis of the final dendrimer, 4.9, was continued without the PEG attached to be 
certain the platinum could be installed.  Compound 4.4 was hydrolyzed in basic solution 
and neutralized with acid to form 4.5.  The barium salt of the carboxylates, 4.6, was 
formed and left in solution.  
Synthesis of the reactive platinum (II) species proceeded using known literature 
procedures.122,123  Tetrachloroplatinum (II) was treated with potassium iodide in aqueous 
solution followed by aqueous ammonium hydroxide to form 4.7.  The diaqua species, 
4.8, was formed by reaction of 4.7 with silver sulfate.  The aqueous solution of 4.8 was 
added to an aqueous solution of 4.6 to form dendrimer 4.9.  The precipitation of BaSO4 
drives the reaction.  After workup of the reaction, a white precipitate was collected.  
Several days passed and the material turned black consistent with Pt0 being formed 
suggesting the intended product was not formed. 
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Figure 4.5.  Synthesis of a Triazine Dendrimer.  a) NaHCO3, acetone/H2O, 0 oC, 3h.  b) 
4.1 (15 eq), DIPEA, CHCl3, RT, overnight.  c) AMP (36 eq), DCM, RT, overnight.  d) 1 
M NaOH (0.41 mL), MeOH, 0 oC, overnight.  e) Ba(OH)2·8H2O (12 eq), H2O, RT.  f) i. 
KI, H2O. ii. NH4OH, H2O.  g) Ag2SO4, H2O, RT, 4h. 
 
 
 
Characterization 
The synthesis of 4.1-4.5 can be followed by 1D NMR or mass spectrometry.  Figure 
4.6 displays the proton NMR spectra of 4.1-4.4.  All spectra were taken in CDCl3 at 
room temperature.  Unlike 2.8, the assignment of the NMR resonances for 4.4 is much 
simpler.  Comparison of the spectra for 4.1 and 4.2 reveals which resonances correlate to 
the ethyl ester and the α proton of the malonate in 4.3 at 1.25, 4.25 and 5.1 ppm.  
Compound 4.4 provides the resonances for 4-aminomethylpiperidine at 1.05 (β), 2.6 (δ), 
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2.7 (α) and 4.7 ppm (α’).  The remaining resonances, β’ and γ, for 4-
aminomethylpiperidine are buried under the resonance at 1.6 ppm.  The proton spectrum 
for the hydrolysis product, 4.5, was not obtained due to poor solubility.  Only mass 
spectral data was obtained to provide evidence that hydrolysis had occurred.  Mass 
spectra for 4.1-4.5 can be found in Appendix C. 
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Figure 4.6.  1H spectra (0.5 – 5.5 ppm) of Compounds 4.1-4.4. 
 
 
 
The platinum compounds were characterized by two methods:  ATR-IR and 195Pt 
NMR.  Figure 4.7 displays the 195Pt NMR spectra of 4.7 and potassium 
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tetrachloroplatinum (II).  Comparison of the two spectra shows the shift of platinum 
nucleus upfield when the tetrachloro complex, – 1624 ppm, is converted to 4.7, – 3280 
ppm.  The chemical shift of 4.7 is similar to those obtained to literature chemical shifts 
of cis-PtI2(NH3)2.124,125  In DMF-d7, Appleton et al. obtained a chemical shift of – 3198 
ppm, while Lippard et al. obtained a chemical shift of – 3264 ppm in CDCl3.  Chemical 
shifts of the trans isomer have not been reported in the literature.  Obtaining a better 
signal to noise ratio was difficult because of poor solubility and amount of time available 
to acquire the spectrum. 
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Figure 4.7.  195Pt NMR spectrum of 4.7 in acetone with a D2O external reference.  Top:  
– 3000 to –3400 ppm.  Bottom:  – 800 to – 3500 ppm. 
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A second characterization technique for 4.7 was employed to verify composition.  
An ATR-IR spectrum was obtained and compared to literature IR spectra of known cis-
PtI2(NH3)2.  Table 2 displays the stretching frequencies of 4.7 and literature values of the 
cis and trans complexes.126  Analysis of the data affords diagnostic signals indicative of 
a cis conformation for 4.7.  Analysis of the data for the known complexes shows distinct 
differences between the two.  Each complex has similar frequencies at 1530 and 1290 
cm-1.  The cis complex has one frequency lower in energy than 1290 cm-1 and one in 
higher energy than 1530 cm-1.  The trans complex has two frequencies higher in energy 
than 1530 cm-1 and none lower in energy than 1290 cm-1.  In the low energy end of the 
spectrum, the cis has two frequencies and the trans has one.  Comparing the frequencies 
of 4.7 with those of the known compounds finds additional stretching frequencies in the 
3200 cm-1 region.  Although the additional frequencies around 3200 cm-1 in 4.7 are not 
reported in Nakamoto’s data, they can attributed to the newer spectrometers having 
better resolution than the ones available to Nakamoto in the 1960s.  Unfortunately, none 
of the frequencies in this region help determine whether 4.7 is cis or trans.  Only one 
frequency of 4.7 in the 1500-1700 cm-1 region matches the cis isomer and none match 
the trans isomer.  In the 1300 cm-1 region, 4.7 displays two signals similarly to the cis 
isomer, trans only has one in this region.  In the final region, 800 cm-1, 4.7 again 
displays two signals like the cis isomer.  This data combined with the 195Pt data suggest 
that 4.7 is cis-Pt I2(NH3)2. 
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Table 2. Observed Frequencies of PtI2(NH3)2
4.7 cis trans Band Assignment 
3348 --- --- 
3274 3294 3268 
3213 3230 3200 
3165 --- --- 
ν(NH) 
    
1668 --- 1620 
1597 1604 1579 
1520 1532 1534 
1288 1293 1290 
1273 1278 --- 
δ(NH3) 
    
810 806 806 
756 752 --- ρr(NH3) 
    
 
 
 
Conclusions 
Though platinum complexes have been used for the treatment of cancer since the 
1970s, the use of dendrimers for platinum conjugation has been recent and limited.  
Dendrimer conjugation of the platinum complexes has shown to be more active than the 
free metal complexes.  The synthetic approach described in this chapter do provide steps 
towards achieving a triazine-based dendrimer-platinum complex, it is not the most 
practical route. 
The biggest issue with this dendrimer is water solubility.  After hydrolysis of the 
esters, neutralization causes the dendrimer to be insoluble in water and organic solvents, 
thus precluding sufficient characterization.  The insolubility of the dendrimer in water is 
probably due to extensive hydrogen-bonding between the carboxylate and the free amine 
of aminomethylpiperidine.  Circumventing this problem could be accomplished in two 
ways (Figure 4.8).  The first approach would be to use the current dendrimer 
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architecture.  Hydrolysis of the esters would occur in the presence of 1 M potassium 
hydroxide.  Removal of the alcohol under reduced-pressure evaporation would leave an 
aqueous solution of the hydrolyzed dendrimer.  Formation of the barium salt, 4.6, is 
accomplished by heating the dendrimer solution and addition of Ba(OH)2·8H2O.127  
Purification of the compound, followed by dissolution in water and finally addition of an 
aqueous solution of 4.8 should produce dendrimer 4.9. 
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Figure 4.8.  First alternate approach to platinate dendrimer. 
 
 
 
The second approach involves the addition of water-solubilization groups at an 
earlier stage of the synthesis (Figure 4.9).  In addition to synthesizing dichloride 4.1, 
monochloro 4.10 would be synthesized as well.  Treating 4.10 with 1-Bocpiperazine 
forms 4.11.  Attachment of amine terminated tetraethyleneglycol is accomplished 
through direct amidation of the esters to form 4.12.  Deprotection of the Boc group 
produces 4.13.  Treatment of 4.3 with 4.13 generates 4.14.  The remaining synthetic 
pathway would proceed through the steps outlined in Figure 4.8 to produce 4.16. 
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Figure 4.9.  Second alternate approach to a platinated dendrimer. 
 
 
 
Each approach should provide platinated dendrimer.  Characterizing the final product 
will be accomplished through 195Pt NMR.  Pellechia and co-workers studied the binding 
sites of tetrachloroplatinum (II) with a G2 or G4 PAMAM dendrimer.128  They were able 
to observe multiple platinum species bound to the dendrimer.  In this study, three general 
platinum species existed:  PtCl3N, PtCl2N2, PtClN3.  Two types of N-bonds were 
available for the platinum to bind, a tertiary nitrogen (NA) and an amide nitrogen (NH).  
With these two types of nitrogens available, the authors were able to deduce that seven 
distinct platinum complexes existed:  PtCl3(NA), PtCl3(NH), PtCl2(NA)2, 
PtCl2(NH)(NA), PtCl(NA)3, PtCl(NA)2(NH), PtCl(NH)3.  Their studies showed a 
preference for the tertiary nitrogen over the amide nitrogen.  Observation of 4.9 and 4.16 
shows many tertiary, secondary and amide nitrogens available for platinum binding.  
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Even with these possible binding sites, the key process involved here is the amount of 
platinum loading able to be determined and can the release be slow enough to reach the 
target but quick enough to provide therapeutic results. 
Experimental Section 
Materials.  Chemicals were purchased from Aldrich, Acros and Strem Chemicals 
and used without further purification.  All solvents were ACS grade and used without 
further purification.  All mass spectral analyses were carried out by the Laboratory for 
Biological Mass Spectrometry at Texas A&M.  Synthetic descriptions for 4.2 can be 
found in the literature.56,121  Selected spectra of the compounds can be found in 
Appendix C. 
Preparation of NMR samples.  All compounds were pumped before use.  
Deuterated solvents were purchased from Acros, used without further purification, and 
kept under moisture free conditions.  Dendrimer samples were prepared in 
concentrations of 0.01—0.1 M solutions.  Non-dendritic platinum samples were 
prepared in 0.01 M solutions in the appropriate solvent; D2O or acetone. 
NMR measurements.  NMR spectra were recorded on a Varian Inova 500 MHz 
spectrometer in CDCl3 or D2O for 1H and 13C spectra.  For 195Pt spectra, the data 
collected using a Varian Inova 400 MHz spectrometer in D2O.  Unless otherwise noted, 
all 1D 1H, 13C and 195Pt spectra were recorded at 25.0 + 0.1 oC.  In CDCl3, 1H spectra 
were referenced to 7.26 ppm and 13C to 77.16 ppm.  In D2O, 1H spectra were referenced 
to 4.79 ppm.  For 195Pt, the spectra were referenced with K2PtCl4 in D2O to – 1624 ppm.  
All 1H spectra were acquired at 500 MHz by using a 1.8 s acquisition time, 5.5 kHz 
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spectral window, and a 3.5 μs pulse width.  All 13C spectra were acquired at 125 MHz by 
using a 2.0 s acquisition time, 22.6 kHz spectral window, 1.0 s relaxation delay and a 5.6 
μs pulse width with WALTZ-16 modulated 1H decoupling.  All 195Pt spectra were 
acquired at 85 MHz by using a 1.0 s acquisition time, 200 kHz spectral window, 1.0 s 
relaxation delay and a 17.0 μs pulse width. 
Mono(diethyl amino malonate)-dichlorotriazine (4.1).  Diethyl-2-
aminomalonate·HCl (10.14 g, 47.94 mmol) was suspended in DCM (480 mL) and 
washed once with saturated Na2CO3 (480 mL).  The organic layer was dried over 
MgSO4 and filtered.  The filtrate was concentrated to give a colorless oil (7.48 g, 42.68 
mmol, 89 %).  The oil was dissolved in cold acetone (70 mL) and NaHCO3 (3.63 g, 
43.16 mmol) was dissolved in cold DI H2O (70 mL).  Cyanuric chloride (7.872 g, 42.68 
mmol) was dissolved in cold acetone (170 mL) and added to cold DI H2O (185 mL) to 
form a slurry.  The malonate solution and the NaHCO3 solution were subsequently 
added to the cyanuric chloride slurry and allowed to stir for 3 hrs at 0 oC.  The mixture 
was filtered and the precipitate was washed several times with DI H2O.  The precipitate 
was dried over P2O5 in vacuo overnight (11.06 g, 80.2 %).  1H NMR (500 MHz, 
CDCl3, δ):  6.90 (d, J = 6.61 Hz, 1H, NH), 5.23 (d, J = 6.94 Hz, 1H), 4.31 (q, J = 7.27 
Hz, 4H), 1.31 (t, J = 7.27 Hz, 6H).  13C NMR (125 MHz, CDCl3, δ):  171.09, 170.74, 
165.19, 63.32, 57.82, 14.12.  MS (ESI) mass calc’d for C10H12Cl2N4O4 = 322.02; found 
323.03 [M+H]+. 
G3-Pip9Cl12Mal12 (4.3).  4.1 (981.4 mg, 3.04 mmol) was added to a solution of 4.2 
(598 mg, 0.202 mmol) and DIPEA (1.40 mL, 8.04 mmol) in CHCl3 (20 mL) at room 
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temperature.  The reaction was allowed to stir overnight.  The following day the solvent 
was removed by reduced – pressure evaporation.  The product was precipitated by 
addition of ethanol.  The precipitation was filtered and washed several times with 
ethanol and dried under vacuum to give a pale yellow precipitate (974.1 mg, 75.3 %).  
1H NMR (500 MHz, CDCl3, δ):  9.63 (brs, NH), 9.45 (brs, NH), 7.0-6.65 (NH), 6.50 
(brs, NH), 6.39 (brs, NH), 6.3-6.15 (NH), 6.04 (brs, NH), 5.45 (brs, 1H), 5.26 (s, 3H), 
5.23 (s, 2H), 5.17 (s, 3H), 5.13 (s, 3H), 4.24 (m, 48H), 3.76 (m, 24H), 3.68 (m, 36H), 
3.59 (m, 24H), 3.45 (m, 12H), 3.40 (m, 12H), 3.32 (m, 12H), 3.22 (m, 12H), 1.90 (m, 
12H), 1.77 (m, 24H), 1.52 (m, 64H), 1.25 (m, 72H).  13C NMR (125 MHz, CDCl3, δ):  
169.86, 168.99, 168.42, 166.49, 166.06, 165.96, 165.57, 165.41, 165.26, 165.05, 164.78, 
164.70, 164.64, 62.72, 62.63, 58.28, 57.72, 44.39, 44.15, 43.65, 43.20, 38.95, 38.43, 
37.70 (br), 29.00, 28.67, 27.79, 25.93, 25.18, 25.07, 14.16.  MS (MALDI) mass calc’d 
for C261H384Cl12N120O48 = 6386.76; found 6388.77 [M+H]+. 
G3-Pip9AMP12Mal12 (4.4).  4-Aminomethylpiperidine (AMP, 200 mL, 1.66 mmol) 
was added to a solution of 4.3 (264.1 mg, 0.0413 mmol) in DCM (10 mL) at room 
temperature.  The solution was allowed to react overnight.  The following day the 
solution was washed 6X with DI water.  The organic layer was dried over MgSO4 and 
filtered.  The filtrate was concentrated and the product precipitated upon addition of 
petroleum ether.  The precipitate was filtered and washed several times with petroleum 
ether to give a colorless solid.  The solid was dissolved in a minimum of DCM and 
reprecipitated from petroleum ether.  The precipitate was washed several times upon 
filtration (213 mg, 70.4 %).  1H NMR (500 MHz, CDCl3, δ):  6.0-5.5 (NH), 5.22 (brs, 
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4H), 5.16 (brs, 8H), 4.69 (m, 24H), 4.22 (m, 48H), 3.72 (m, 60H), 3.56 (m, 36H), 3.29 
(m, 36H), 2.68 (m, 24H), 2.56 (m, 24H), 1.71 (m, 54H), 1.65-1.38 (m, 72H), 1.25 (m, 
72H), 1.05 (m, 24H).  MS (MALDI) mass calc’d for C333H540N144O48 = 7324.42; found 
7333.34 [M+H]+. 
G3-Pip9AMP12MalH12 (4.5).  To a solution of 4.4 (211.6 mg, 0.0289 mmol) in 
MeOH (2.8 mL) was added 1M NaOH (aq) (0.41 mL, 0.41 mmol) at 0 oC.  The reaction 
was allowed to stir for 24 hours at 0 oC.  The reaction was allowed to warm to room 
temperature and neutralized to pH 7.  Upon neutralization, a white precipitate formed.  
The precipitate was filtered and washed with MeOH several times and twice with DI 
water to remove NaCl salts.  The precipitate was dried under vacuum (142.66 mg, 74.2 
%).  MS (MALDI) mass calc’d for C285H444N144O48 = 6651.67; found 6369.32 [M+H]+. 
PtI2(NH3)2 (4.7).  Potassium iodide (3.807 g, 22.93 mmol) was added to a solution 
of potassium tetrachloroplatinum(II) (2.024 g, 4.876 mmol) in DI water (24 mL) at room 
temperature.  Once all the KI dissolved, a solution of NH4OH (0.82 mL) in DI water 
(0.82 mL) was added.  After several minutes, a mustard yellow precipitate formed.  The 
mixture was transferred to a 50 mL centrifuge tube and was centrifuged at 5000 rpm for 
30 min three times.  In between each run, the supernatant was decanted and the 
precipitate resuspended in DI water.  The solid was dried over P5O5 in vacuo (2.254 g, 
95.7 %).  195Pt NMR (85 MHz, D2O, δ):  – 3280. IR (cm-1):  ν(N-H) 3348w, 3274s, 
3213s, 3165m, δ(NH3) 1668w, 1597m, 1520w, 1288s, 1273s, ρr(NH3) 810w, 756m. 
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CHAPTER V 
SUMMARY 
 
Many studies have defined a general picture of the conformation of dendrimers.  The 
analyses have been both experimental and theoretical.6-41,79,80  Most studies conclude that 
dendritic arms backfold to some extent, especially at higher generations.  The 
environment of the dendrimer will affect the extent of backfolding.7-15,19-23,25,35,36  The 
dendrimer system described in this dissertation describes how one system can be used to 
describe most, if not all, the general concepts described in other dendrimer systems. 
The synthesis of the dendrimer started with the selection of diamine linkers.  To 
utilize the diamines under unprotected conditions, they needed to meet certain criteria:  
20–fold differential reactivity between the amines, presence of unique NMR signals and 
commercial availability.  Previous competition studies between various diamines 
provided a relative nucleophilic reactivity of amines towards a model 
monochlorotriazine.42  Expansion of this reactivity chart included several cyclic amines, 
G-K (Figure 2.1), and extended the reactivity to greater than 320X compared to 
benzylamine.  From these studies three linkers were chosen that met the criteria:  
aminoazetidine (L1), aminopyrrolidine (L2) and aminopiperidine (L3).  Aminoazetidine 
(L1) offers a highly reactive and sterically unencumbered amine that might find use in 
situations where piperidine-type amines are unreactive or sluggish.  Aminopyrrolidine 
(L2) offers opportunities to explore chiral environments in these dendrimers.  
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Aminopiperidine (L3) offers an inexpensive linker that aligns with the group’s current 
reliance on aminomethylpiperidine groups.   
These linkers convey spectroscopically unique signatures to different regions of the 
dendrimer architecture; an effect only rarely observed in related architectures.27,35,62-65  
The presence of the unique signatures allowed one to follow the synthesis of the 
dendrimer by observing shifts of certain protons on each linker.  In all, seven protons, 
excluding NHs, were identified by TOCSY spectra to be unique signals:  HP’,K,K’,L,Q, T’. 
The NH-region of the spectrum that provides insight into the complexity of the 
structure of the dendrimer that suggests a rich population of rotamers exists.  The 
carbamate NH populations do not change throughout the synthesis, while significant 
changes were observed for the pyrrolidine NH populations.  An initial 2:1 ratio of 
(E,E):(E,Z) expected for a conformationally unhindered molecule shifted a 1:1.3 ratio 
indicative of a sterically congested architecture. 
Conformational analysis in DMSO reveals the presence of general concepts of 
dendrimer conformation.  Previously published reports show that backfolding is a 
common feature of dendritic structure.7-10,13-17,19-21,26,27,31,33,35  Two-dimensional NMR 
studies showed that the peripheral groups of the triazine dendrimer backfolded and 
interacted with the pyrrolidine groups.  Lowering of the concentration did not remove 
these interactions nor did an increase in temperature.  A change in conformation was 
observed upon changing the solvent from DMSO to chloroform or methanol.  Similarly, 
Rinaldi and co-workers observed comparable results with PPI dendrimers.35  Several 
experimental studies, including simulations, have suggested that the conformation of the 
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dendrimer can be changed either through a change in solvent, pH or ionic 
concentration.8,11-14,22,23,25,35,36  Interbranch communication within the dendritic structure 
was observed through the use of model compounds and 2D NOESY spectra.  In an 
attempt to identify the many cross-peaks of the dendrimer NOESY spectrum (Figure 
3.3), the mixing time of the experiment was decreased to eliminate the possibility of spin 
diffusion occurring.81  Analysis of the model compounds, 2.1 and 2.2, shows evidence 
that interbranch communication was occurring. 
Relaxation studies of PAMAM, PPI and polyaryl ether dendrimers show that the 
exterior of the dendrimer has more mobility and the interior of the dendrimer.16,17,27,31,35  
This system not only agrees with these studies but also provides evidence that each layer 
of the dendrimer has different mobilities.  
Finally, attempts to synthesize a pharmacologically active triazine dendrimer were 
unsuccessful using the synthetic route taken.  There are few reports in the literature of 
conjugating platinum to dendritic systems.118-121,129  Changes in the synthetic route 
would provide water soluble dendrimer.  Characterization of the complex would be 
accomplished by 1H, 13C, and 195Pt NMR, IR and mass analysis.  Future studies of this 
complex include pharmacokinetic data and biodistribution to evaluate the dendrimer’s 
biological significance. 
This dissertation has described the use of triazine dendrimers to provide a general 
conceptual image of dendrimer conformation and the synthesis of a dendrimer prodrug.  
These two systems should give insight into the versatility of our triazine dendrimers and 
provide outlets for biological applications. 
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APPENDIX A 
SELECTED NMR SPECTRA FOR COMPOUNDS DESCRIBED IN CHAPTER II 
Intermediate 2.1 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.1 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.2 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.2 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.2 – (1H–1H) COSY Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.3 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.3 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.3 – (1H–1H) COSY Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.4 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.4 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.4 – (1H–1H) COSY Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.5 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.5 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.6 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Intermediate 2.6 – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Dendrimer (2.8) – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Dendrimer (2.8) – 13C Spectrum (CDCl3, T = 25 oC) 
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Model 2.9 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.2 & 2.9 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Model 2.10 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.3 & 2.10 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Model 2.11 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.8 & 2.11 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Model 2.12 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.4 & 2.12 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Model 2.13 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.5 & 2.13 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Model 2.14 – 1H Spectrum (DMSO-d6, T = 25 oC) 
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2.8 & 2.14 – 1H Spectra Comparison (DMSO-d6, T = 25 oC) 
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Table 3.  Rotamer Populations - 1a
Compound Boc Pyr Pip Az 
Atrazineb 5(EEt,EiPr):3(ZEt,EiPr):3(EEt,ZiPr):1(ZEt,ZiPr)  
2.1 12 : 1    
2.2 8 : 7 : 1    
2.3 9 : 8 : 1 13 : 6 : 1   
2.4 12 : 10 : 1c d   
2.5 7 : 6 : 1 2.5 : 1 3 : 8 : 1 : 4 : 1  
2.6    1 : 1 : 1 : 1 
2.8 9 : 9 : 1e 1 : 1.3 d f
3.3 17 : 1    
2.9     
2.10  14 : 5 : 5 : 1   
2.11  10 : 4 : 1   
2.12     
2.13   5 : 4 : 4 : 1  
2.14   7 : 4 : 1  
aRatios relate to most downfield NH to most upfield NH for each type.  Refer to Figure 4 
of manuscript. 
bRefs. 74-75 
cRatio includes Pyr-NH. 
dRatio not determined due to resonances buried under Boc resonances. 
eRatio includes Pip-NH. 
fRatio not determined due to the broadness of the peaks 
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Highlighted in red are the atoms involved in determined the syn or anti conformation of 
the carbamate bond.  Comparing the model compound to 2.1, the anti conformation is 
clearly favored over the syn conformation in a 17:1 and 12:1 respectively.  This 
correlates well with literature values of anti:syn ratio being 10:1.71  The spectrum of 2.1 
provides potentially more complexity than just the syn and anti conformations.  The 
resonance for the anti conformation is two triplets overlapping one another.  This may 
due to two of the carbamates being influenced by the deshielding effects of the chlorine 
atom. 
Table 4.  Rotamer Populations - 2 
Compound Anti:Syn 
2.1 12:1 
3.3 17:1 
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Analysis of this spectrum provides evidence that the carbamate resonances 
are being influenced by the third substituent on the triazine ring, in this 
case 3-aminopyrrolidine.  Here we are able to more distinctly observe the 
two environments of the anti conformation.  Comparison of this ratio with 
2.1 does not show any significant difference 
Table 5.  Rotamer Populations - 3 
Compound Boc Pyr 
2.1 12:1  
3.3 17:1  
2.2 8:7:1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparison of 2.3 and 2.10 identifies the rotamers of the pyrrolidine-NH.  
The deshielding effects of the chlorine atom shift the resonances far 
downfield.  Model 2.10 shows four distinct doublets in a 14:5:5:1 ratio.  In 
2.3, this ratio is 13:6:1.  The two different chemical shifts for the (E,Z) 
rotamer of M2 has yet to be explained.  Observance of the carbamate 
resonances and a shoulder appears for one of the anti resonances. 
Table 6.  Rotamer Populations - 4 
Compound Boc Pyr 
2.1 12:1  
3.3 17:1  
2.2 8:7:1  
2.3 9:8:1 13: :1 6
2.10  14:5:5:1 
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By displacing the chlorine with either pyrrolidine, for 2.11, or 4-
aminopiperidine, for 2.4, the deshielding effects of the chlorine atom are 
removed.  We observe a shift upfield of the pyrrolidine resonances.  
Comparing the model compound with 2.4, suggests that we should 
observe three resonances for the pyrrolidine-NH.  The only pyrrolidine-
NH observed is for the (E,E) rotamer.  COSY correlations identifies 
another pyrrolidine-NH, (E,Z), overlapping the anti resonances of the 
carbamate.  We attribute this overlapping for the increase in the anti:syn 
ratio. 
Table 7.  Rotamer Populations - 5 
Compound Boc Pyr 
2.1 12:1  
3.3 17:1  
2.2 8:7:1  
2.3 9:8:1 13:6:1 
2.10  14:5:5:1 
2.4 12: 0:1 1 * 
2.11  10:4:1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.  Rotamer Populations - 6 
Compound Boc Pyr Pip 
2.1 12:1   
3.3 17:1   
2.2 8:7:1   
2.3 9:8:1 13:6:1  
2.10  14:5:5:1  
2.4 12:10:1 *  
2.11  10:4:1  
2.5 7:6:1 2.5:1 3:8:other 
2.13   5:4:4:1 
As with 2.10, 2.12 displays two sets of resonances for the (E,Z) rotamer.  As before, we have not been able explain this.  
Intermediate 2.5 also displays a complex rotamer pattern.  Using TOCSY correlations we have been able to determine that five 
different resonances exist.  We have decided to list the ratio as 3:8:other due to the other resonances being much lower.  The 
additional resonances may be due to a protonation event occurring, ring flipping or the globular structure of the molecule.  The 
pyrrolidine-NH resonances are now observed with a 2.5:1 ratio.  This is not much different from compound 2.2.  The ratio 
observed for the carbamate resonances, 7:6:1, helps support our assumption that the pyrrolidine-NH was the cause for the 
slight increase in 2.4. 
 
 
 
 
 
 
 135
 
  
136
8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1 6.0
Chemical Shift (ppm)
1
2
2.5
2.13
(Z,Z)(E,Z)(E,E)
N N
NNH NH
Cl
N N N N
NNH NH
Cl
N
N N N
NNH NH
Cl
N N
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9.  Rotamer Populations - 7 
Compound Boc Pyr Pip 
2.1 12:1   
3.3 17:1   
2.2 8:7:1   
2.3 9:8:1 13:6:1  
2.10  14:5:5:1  
2.4 12:10:1 *  
2.11  10:4:1  
2.5 7:6:1 2.5:1 3:8:other 
2.13   5:4:4:1 
2.8 9:9:1 1:1.3 ** 
2.14   7:4:1 
Model 2.14 shows where the resonances for the piperidine-NH rotamers should be in 2.8.  With 2.8, we are only able to 
determine the ratios of the pyrrolidine and carbamate resonances.  The azetidine-NH was too broad to integrate.  The 
carbamate resonances are increased due to the piperidine-NH resonances being overlapped here as well.  The pyrrolidine-NH 
resonances show a distinct shift towards favoring the (E,Z) rotamer with a 1:1.3 ratio.  This shows that the globular shape of 
the dendrimer is influencing the preferred conformation of the rotamers. 
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APPENDIX B 
SELECTED NMR SPECTRA FOR COMPOUNDS DESCRIBED IN CHAPTER III 
Dendrimer (2.8) – 1H Spectrum (CDCl3, T = 25 oC) 
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 Dendrimer (2.8) – 1H Spectrum (CD3OD, T = 25 oC) 
140
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
2.8
HI'
HJ
HI
HL'
HK
'
HL
R'"R"R'
HO'
HQ
HP
HO
HP'
HP'
HO
HO'
HT
HU
HT'
HT' R'" =R" =R' = A
DEF
R =
N N
N NH N
N N
N NNNHN
N N
NNHN
N N
R
R NH
NHBoc
O
O
HKHPHT
X
X
X
X
X
+P
K+P'
K'
+O
+I+L
L'
T'
AED
F
Q+I'+T
J
O'
H2O+
U
 
 
Dendrimer (2.8) – (1H–1H) NOESY Spectrum (CDCl3, T = 35 oC) 
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Dendrimer (2.8) – (1H–1H) NOESY Spectrum (CD3OD, T = 35 oC) 
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2,4-Bis(p-toluidine)–6-(1-Boc-3-amino-azetidine)-1,3,5–triazine – 1H Spectrum (CDCl3, T = 25 oC) 
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2,4-Bis(p-toluidine)-6-(1-Boc-3-amino-azetidine)-1,3,5-triazine
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2,4-Bis(p-toluidine)–6-(1-Boc-3-amino-azetidine)-1,3,5–triazine – 13C Spectrum (CDCl3, T = 25 oC) 
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Arm Model (3.1) – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Arm Model (3.1) – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Arm Model (3.1) – (1H–1H) NOESY Spectrum 1–5 ppm (DMSO-d6, T = 35 oC) 
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Mono(p-toluidine)-dichlorotriazine (pTolCl2) – 1H Spectrum (CDCl3, T = 25 oC) 
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Mono(p-toluidine)-dichlorotriazine (pTolCl2) – 13C Spectrum (CDCl3, T = 25 oC) 
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Mono(p-toluidine)-mono(Bis(3-Boc-3-aminopropyl)amine)-monochlorotriazine (pTol-BBT-Cl) – 1H Spectrum (DMSO-
d6, T = 25 oC) 
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Mono(p-toluidine)-mono(Bis(3-Boc-3-aminopropyl)amine)-monochlorotriazine (pTol-BBT-Cl) – 13C Spectrum (DMSO-
d6, T = 25 oC) 
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Mono(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidinotriazine (pTol-BBT-Pyr) – 1H Spectrum 
(DMSO-d6, T = 25 oC) 
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Mono(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidinotriazine (pTol-BBT-Pyr) – 13C Spectrum 
(DMSO-d6, T = 25 oC) 
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Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monochlorotriazine (pTol2-BBT-Pyr-Cl) – 
1H Spectrum (DMSO-d6, T = 25 oC) 
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Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monochlorotriazine (pTol2-BBT-Pyr-Cl) – 
13C Spectrum (DMSO-d6, T = 25 oC) 
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Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monopiperidinotriazine (pTol2-BBT-Pyr-
Pip) – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Bis(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monopiperidinotriazine (pTol2-BBT-Pyr-
Pip) – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Tris(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monopiperidine-monochlorotriazine 
(pTol3-BBT-Pyr-Pip-Cl) – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Tris(p-toluidine)-mono(Bis(3-BOC-3-aminopropyl)amine)-monopyrrolidine-monopiperidine-monochlorotriazine 
(pTol3-BBT-Pyr-Pip-Cl) – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Linear Model (3.2) – 1H Spectrum (DMSO-d6, T = 25 oC) 
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Linear Model (3.2) – 13C Spectrum (DMSO-d6, T = 25 oC) 
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Linear Model (3.2) – (1H–1H) NOESY Spectrum 1–5 ppm (DMSO-d6, T = 35 oC) 
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APPENDIX C 
SELECTED NMR SPECTRA FOR COMPOUNDS DESCRIBED IN CHAPTER IV 
Intermediate 4.1 – 1H Spectrum (CDCl3, T = 25 oC) 
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Intermediate 4.1 – 13C Spectrum (CDCl3, T = 25 oC) 
75 70 65 60 55 50 45 40 35 30 25 20 15 10
Chemical Shift (ppm)
175 170 165 160
Chemical Shift (ppm)
4.1
N N
NCl
Cl
NH
CO2Et
O
O
A
B
D
C
A
B D
C
Triazine C's
 
164
 
Mono(diethyl amino malonate)-dichlorotriazine (4.1) – ESI-MS Spectrum  
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G3-Pip9Cl12Mal12 (4.3) – 1H Spectrum (CDCl3, T = 25 oC) 
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G3-Pip9Cl12Mal12 (4.3) – 13C Spectrum (CDCl3, T = 25 oC) 
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G3-Pip9Cl12Mal12 (4.3) – MALDI-MS Spectrum 
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G3-Pip9AMP12Mal12 (4.4) – 1H Spectrum (CDCl3, T = 25 oC) 
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G3-Pip9AMP12Mal12 (4.4) – MALDI-MS Spectrum 
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G3-Pip9AMP12MalH12 (4.5) – MALDI-MS Spectrum 
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